CA2309342A1 - Protein production in transgenic plant seeds - Google Patents
Protein production in transgenic plant seeds Download PDFInfo
- Publication number
- CA2309342A1 CA2309342A1 CA 2309342 CA2309342A CA2309342A1 CA 2309342 A1 CA2309342 A1 CA 2309342A1 CA 2309342 CA2309342 CA 2309342 CA 2309342 A CA2309342 A CA 2309342A CA 2309342 A1 CA2309342 A1 CA 2309342A1
- Authority
- CA
- Canada
- Prior art keywords
- seed
- transgenic
- plant
- promoter
- transgenic plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 155
- 230000014616 translation Effects 0.000 title description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 55
- 102000004190 Enzymes Human genes 0.000 claims abstract description 48
- 108090000790 Enzymes Proteins 0.000 claims abstract description 48
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 21
- 239000002773 nucleotide Substances 0.000 claims abstract description 8
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims description 99
- 240000007594 Oryza sativa Species 0.000 claims description 87
- 235000007164 Oryza sativa Nutrition 0.000 claims description 85
- 235000009566 rice Nutrition 0.000 claims description 84
- 108010011619 6-Phytase Proteins 0.000 claims description 72
- 229940085127 phytase Drugs 0.000 claims description 66
- 108090000637 alpha-Amylases Proteins 0.000 claims description 62
- 229940088598 enzyme Drugs 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 35
- 239000004382 Amylase Substances 0.000 claims description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 17
- 229920001184 polypeptide Polymers 0.000 claims description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 16
- 108010068370 Glutens Proteins 0.000 claims description 12
- 210000001161 mammalian embryo Anatomy 0.000 claims description 8
- 238000003306 harvesting Methods 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 241000209056 Secale Species 0.000 claims description 2
- 235000007238 Secale cereale Nutrition 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 claims 1
- 241000209763 Avena sativa Species 0.000 claims 1
- 235000007558 Avena sp Nutrition 0.000 claims 1
- 240000000385 Brassica napus var. napus Species 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 50
- 230000000694 effects Effects 0.000 description 50
- 108091034117 Oligonucleotide Proteins 0.000 description 37
- 210000004027 cell Anatomy 0.000 description 34
- 108020004707 nucleic acids Proteins 0.000 description 30
- 102000039446 nucleic acids Human genes 0.000 description 30
- 150000007523 nucleic acids Chemical class 0.000 description 30
- 108010076504 Protein Sorting Signals Proteins 0.000 description 26
- 101150050411 appA gene Proteins 0.000 description 26
- 101100148259 Actinobacillus pleuropneumoniae apxIIA gene Proteins 0.000 description 23
- 239000013612 plasmid Substances 0.000 description 18
- 108020005345 3' Untranslated Regions Proteins 0.000 description 17
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 16
- 239000012634 fragment Substances 0.000 description 16
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 15
- 229930006000 Sucrose Natural products 0.000 description 15
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 239000005720 sucrose Substances 0.000 description 15
- 235000000346 sugar Nutrition 0.000 description 15
- 239000000725 suspension Substances 0.000 description 15
- 235000002949 phytic acid Nutrition 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 13
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 12
- 101150015369 apu gene Proteins 0.000 description 12
- 239000011574 phosphorus Substances 0.000 description 12
- 229910052698 phosphorus Inorganic materials 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 230000009466 transformation Effects 0.000 description 11
- 150000008163 sugars Chemical class 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 240000008042 Zea mays Species 0.000 description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
- 235000005822 corn Nutrition 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 108010051457 Acid Phosphatase Proteins 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- 108700019146 Transgenes Proteins 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 7
- 102000013563 Acid Phosphatase Human genes 0.000 description 7
- 241000589158 Agrobacterium Species 0.000 description 7
- 108700026244 Open Reading Frames Proteins 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000035784 germination Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 4
- 241000235648 Pichia Species 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 235000003642 hunger Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 230000037351 starvation Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 108020005065 3' Flanking Region Proteins 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- 241000235058 Komagataella pastoris Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 241000186337 Thermoanaerobacter ethanolicus Species 0.000 description 3
- 108091036066 Three prime untranslated region Proteins 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000004464 cereal grain Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 241000605031 Selenomonas ruminantium Species 0.000 description 2
- 240000006394 Sorghum bicolor Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 244000275904 brauner Senf Species 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- LXJXRIRHZLFYRP-UHFFFAOYSA-N glyceraldehyde 3-phosphate Chemical compound O=CC(O)COP(O)(O)=O LXJXRIRHZLFYRP-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- MTWNQMHWLWHXGH-XEUPFTBBSA-N pag 8 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](OC(C)=O)[C@@H]1OC(C)=O)OC(C)=O)OC[C@H](C(C1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]([C@H]1OC(C)=O)O[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(O)=O)[C@@H]([C@H]1OC(C)=O)O[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]([C@H]1OC(C)=O)O[C@@H]1O[C@@H]([C@H]([C@H](O[C@H]2[C@@H]([C@@H](OC(O)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O2)OC(C)=O)[C@H]1OC(C)=O)OC(C)=O)COC(=O)C)C(O)=O)[C@@H](OC(C)=O)[C@@H](C(CC(C(C)=O)C(C)=O)OC(C)=O)C(C(C)=O)C(C)=O)OC(=C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O MTWNQMHWLWHXGH-XEUPFTBBSA-N 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 108700022487 rRNA Genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- FRGKKTITADJNOE-UHFFFAOYSA-N sulfanyloxyethane Chemical compound CCOS FRGKKTITADJNOE-UHFFFAOYSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150048253 PHYA gene Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 241000201976 Polycarpon Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- HOZOZZFCZRXYEK-GSWUYBTGSA-M butylscopolamine bromide Chemical compound [Br-].C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)CCCC)=CC=CC=C1 HOZOZZFCZRXYEK-GSWUYBTGSA-M 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 101150029559 hph gene Proteins 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004890 malting Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000007030 peptide scission Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229940016590 sarkosyl Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
A transgenic plant whose genomic DNA includes a gene having a promoter and a nucleotide sequence encoding an enzyme and operably linked to the promoter, in which the promoter drives expression of the hydrolytic enzyme in plant seed tissue of a developing seed, germinating seed, germinated seed, or seedling of the transgenic plant.
Description
PROTEIN PRODUCTION IN TRANSGENIC PLANT SEEDS
Background of the Invention The use of transgenic plants for the production of pharmaceutical proteins and industrial enzymes has been proposed. In general, expression of recombinant proteins relies on stable integration of a heterologous gene into a host plant genome using, e.g., Agrobacterium-mediated transformation or particle bombardment. In terms of cost, production of commercially valuable proteins using crops in the field is more competitive than other biological production systems (such as yeast, 10 bacteria, or mammalian cell cultures) which require complex and high-maintenance bioreactors. Further, protein production in plant can be easily scaled-up to produce large quantities.
Summary of the Invention 15 The invention is based on the discovery that hydrolytic enzymes have a specific activity higher than expected (as compared to, e.g., E. coli produced enzyme) when expressed in transgenic seeds using a transgene having a promoter active in a plant seed tissue and driving transcription of a sequence encoding the hydrolytic enzyme.
20 More specifically, the invention features a transgenic plant (e.g., a transgenic rice, barley, rye, or canola plant) whose genomic DNA includes a gene having a promoter (e.g., an a-amylase promoter, such as that of the aAmy8 gene, or a glutelin promoter) and a nucleotide sequence encoding a hydrolytic enzyme and operably linked to the promoter. The promoter drives expression of the hydrolytic enzyme in 25 a plant seed tissue of a developing seed, germinating seed, germinated seed, or seedling of the transgenic plant. The enzyme optionally hydrolyzes a substrate naturally occurring in a plant seed tissue. If the enzyme is a phytase, the enzyme can also be an acid phosphatase, such as the enzyme encoded by an appA gene, or a phytase from Selenomonas ruminantium (e.g., strain JY35, available as ATCC
30 55785), such as the enzyme encoded by the phyA gene. If the enzyme is a amylopullulanase (e.g., of Therrnoanaerobacter ethanolicus), the enzyme can also be an a-amylase. The invention also includes a transgenic seed produced from a transgenic plant as described above. As used herein, a "seed" can be a developing seed, a mature seed, a germinating seed, a germinated seed, or a seedling.
Thus, the 5 invention further features a method of producing a hydrolytic enzyme by providing a transgenic plant of the invention, harvesting a transgenic seed from the transgenic plant, germinating the seed, and optionally isolating the hydrolytic enzyme from the transgenic seed.
The invention also features a method of producing a polypeptide by 10 providing a transgenic plant whose genomic DNA contains a gene having an a-amylase promoter and a nucleotide sequence encoding a polypeptide and operably linked to the promoter; harvesting a transgenic seed from the transgenic plant;
germinating the transgenic seed to produce a mature seed; and isolating the polypeptide from the mature seed (e.g., from an embryo or endosperm tissue of the 15 mature seed). Also included in the invention is a method of producing a polypeptide by providing a transgenic plant whose genomic DNA contains a gene having a glutelin gene promoter and a nucleotide sequence encoding a polypeptide and operably linked to the promoter; harvesting a transgenic seed from the transgenic plant; germinating the transgenic seed; and isolating the polypeptide from an embryo 20 or endosperm tissue of the seed.
As used herein, a "phytase" is an enzyme that reacts with phytate or phytin to release phosphorus or a moiety that contains phosphorus that is absorbable in the GI
of a monogastric animal. Thus, a phosphatase that releases inorganic phosphorus or phosphate from phytate is also a phytase.
25 By one genetic element being "operably linked" to another is meant that one genetic element (either in a plus strand, minus strand, or double stranded form) is structurally configured to operate or affect another genetic element. For example, a promoter operably linked to a sequence encoding a polypeptide means that the promoter initiates transcription of a nucleic acid encoding the polypeptide.
Germination begins with water uptake by the seed (imbibition) and ends with the start of elongation by the embryonic axis, usually the radicle. Therefore, germination does not include seedling growth, which commences when germination terminates. For germination to be completed, the radicle must expand and penetrate 5 the surrounding structures. A developing seed is one that is germinating or supporting growth of the seedling. As used herein, the term "seedling" means the juvenile plant grown from a germinating seed, as defined in de Vogel, "The Seedling," In: Seedlings of Dicotyledons, Centre for Agricultural Publishing and Documentation, Wageningen, Netherlands, pp 9-25, 1983 An a-amylase gene promoter and signal peptide sequence can be fused upstream of the enzyme open reading frame (ORF) or gene, which can be derived from various sources. The chimeric gene is then introduced into a plant (e.g., cereal) genome. For example, a malted transgenic cereal grain that produces high levels of phytase can be used for human consumption, animal feed, or food processing.
Malting is the process by which grains are germinated under controlled condition and in contained facilities to produce a consistent product.
The advantages of using transgenic malted seeds to produce a hydrolytic enzyme as feed include: (1) the seeds contain a large quantity of nutrient and minerals in an easily available form that is easily transportable and not readily 20 perishable; (2) the nutrients in the seeds are not chelated by, e.g., phytate; (3) in the case of malted seeds, little toxicity is expected for consumers of the feed, because the malted seeds have long been used in the brewing and food industries and are known to be harmless to humans and animals; and (4) the cost of manufacturing feed for monogastric animals is reduced because an exogenous enzyme does not need to be added to the raw material.
In addition, the transgenic plants of the irwention, or organs and seeds thereof, can be used to produce hydrolytic enzymes for a variety of industrial processes. Examples of such applications are in feed additives for non-ruminants, in soy processing, in food processing, or in the production of inositol or inositol-phosphates from phytate.
Other features or advantages of the present invention will be apparent from the following detailed description, and also from the claims.
Brief Description of the Drawings Fig. 1 is a line graph of pH versus phytase activity.
Fig. 2 is a line graph of pH versus acid phosphatase activity.
Fig. 3 is a bar graph of various transgenic plants versus amount of APU
produced therein. The filled bars represent plant samples grown in sucrose.
The open bars represent plant samples grown without sucrose. "NT" is the non-transformed control.
Figs. 4 and 5 are bar graphs of various transgenic lines versus amount of APU. "NT" is the non-transformed control.
Fig. 6 is a bar graph of various transgenic lines versus specific activity for APU.
Figs. 7 and 8 are bar graphs of various transgenic lines versus sugar concentration. "NT" is the non-transformed control.
Detailed Description of the Invention The invention relates to transgenic plants that produce seeds useful as the 20 raw material for a phosphorus or carbohydrate-rich feed. The superior quality of the seeds and the resulting feed is due to the insertion of a transgene containing a promoter active in a plant seed tissue and that highly expresses an enzyme in a seed tissue of a transgenic plant. Of course, the enzyme may be expressed elsewhere in a transgenic seed or plant without affecting the advantages that the invention offers.
Seeds produced from such a plant can have reduced phytate and increased dietary phosphorus content, or reduced complex carbohydrates and increased simple carbohydrates, compared to a control plant that does not contain the transgene.
Phytate (myo-inositol hexakisphosphate) is the main storage form of phosphorus in many seeds. Phytin is the insoluble mixed potassium, magnesium, and calcium salt of myo-inositol hexaphosphoric acid (phytic acid). In cereals, oil seeds, and legumes, phytate accumulates in seeds during maturation and accounts for 50 to 80% of total phosphorus content of the seed. Soybean and corn meal are major components of animal feed. They contain adequate phosphorus levels to meet animal growth requirements, so long as phosphorus from the phytate is digestible 5 (i.e., absorbable) by the animal. Ruminants (multigastric animals) readily cleave phytate to release digestible phosphorus. However, monogastric animals (e.g., pigs, poultry, and fish) utilize phytate extremely poorly because they are deficient in gastrointestinal (GI) tract enzymes capable of hydrolyzing phytate. This deficiency necessitates supplementation of animal feed with phosphorus to meet dietary 10 requirements. Further, phytate chelates important cations (including iron, magnesium, manganese, zinc, calcium, copper, and molybdenum) and forms phytate-cation-protein complexes, thereby lowering the bioavailability of minerals and amino acids in the feed. Thus, the invention provides a means to release phosphorus by degrading phytate in raw materials used for animal feed.
15 Phytase produced in a transgenic plant or seed of the invention can also be used in a process for steeping corn or sorghum kernels. The plant tissue or seed can be ground before adding to steeping corn. Phytase liberated from the plant tissue or seed can act on phytin, which is present in many corn preparations. The transgenic cereal grains, if they are corn or sorghum grains, can produce phytase to degrade 20 phytin in situ. Degradation of phytin in corn steeping increases the nutrient content and consequently the commercial value of corn steep liquor, which is used as animal feed or as a nutrient in microbial fermentation. Furthermore, the degradation of phytin can prevent problems relating to the accumulation of phytin deposits in filters, pipes, reactor vessels, etc. during concentration, transport and storage of corn 25 steep liquor. The action of phytase can also accelerate the steeping and separation processes involved in corn wet milling. _ In addition, the use of transgenic seeds containing starch-hydrolyzing enzymes (e.g., amylopullulanase) is compatible and desirable with currently used processes in food and wine industries for production of sugars using cereal grain 30 starch. Rice provides the main source of food for more than 50% of the world population and is the most important and widely grown crop on earth. Due to the large biomass, rice seeds are an ideal sources of soluble sugars for the food and wine industries. Amylopullulanase (APU) from Thermoanaerobacter ethanolicus 39E, harboring both pullulanase and a-amylase activities, is capable of hydrolyzing both 5 a-1,4 and a-1,6 bonds of polysaccharides and is heat stable with a catalytic optimum of 90°C. Generally, rice contains 6-10% protein and 70-80%
starch by weight. APU can hydrolyze the starch to produce soluble sugars and at the same time increase the relative composition of insoluble rice flour. High protein rice flour has high nutritional value and is useful for the production of pudding, gruel, instant 10 milk, baby food, etc. As shown below, a 2.9-kb DNA fragment of the APU gene that encodes amino acids 75 to 1029 of the mature APU (total of 1481 amino acids) of T. ethanolica~s was isolated and characterized. This truncated APU
maintains both a-amylase and pullulanase activities. The use of transgenic rice seeds containing the dual active APU in the production of sugars from seed starch 15 simplifies the production process and significantly reduces production cost for rice flour.
The genetic elements necessary for constructing the transgene to be inserted into the plant is readily available. For example, a-amylase promoters are described in U.S. Patent No. 5,460,952 and in the Example below. Other suitable promoters 20 are described in McElroy et al., Plant Mol. Biol. 15:257-268, 1990;
Brusslan et al., Proc. Natl. Acad. Sci. USA 89:7791-7795, 1992; Wissenbach et al., Plant J.
4:411-422, 1993; Reynolds et al., Plant Mol. Biol. 29:885-896, 1995; Kaukinen et al., Plant Mol. Biol. 30:1115-1128, 1996; Beaudoin et al., Plant Mol. Biol. 33:835-846, 1997;
Moore et al., Proc. Natl. Acad. Sci. USA 94:762-767, 1997; Odell et al., Nature 25 313:810-812, 1985; and U.S. Patent Application entitled "Plant Seedling and Embryo Promoter," filed May 22, 2000, naming-inventors Su-May Yu and Yu-Chan Chao. Other genetic elements, such as cis-regulatory sequences are also available to the skilled artisan. See, e.g., U.S. Patent No. 5,969,127.
The expression constructs containing the transgene can be inserted into a 30 vector, such as a plasmid, which is then introduced into plants using Agrobacterium tumefaciens-mediated DNA delivery or particle bombardment, which are standard methods known in the art.
The DNA sequence encoding an enzyme may be obtained from a variety of sources such as microbial, plant, or animal sources. For example, a DNA
sequence encoding a phytase can be cloned from a ruminal bacterium by, e.g., screening of bacterial cDNA libraries or PCR amplification of nucleic acids using heterologous or degenerate probes.
The cloned genes described herein may be used as starting materials for the construction of "second generation" enzymes whose amino acid sequence has been altered by mutagenesis (e.g., site-directed mutagenesis), which have beneficial properties that differ from those of wild-type or recombinant enzymes. For example, the temperature or pH optimum, specific activity, or substrate affinity can be altered so as to be better suited for application in a defined process.
Several techniques are available for the introduction of the expression 15 construct containing the enzyme-encoding DNA sequence into plants or cells from which transgenic plants can be produced. Such techniques include electroporation, microinjection, the ultrasonic method, polyethylene glycol-mediated protoplast transformation, the poly-L ornithine method, the calcium phosphate method, and particle bombardment.
In addition to these so-called direct DNA transformation methods, transformation systems involving vectors are widely available, such as viral vectors (e.g., from the cauliflower mosaic virus, CaMV) and bacterial vectors (e.g., from the genus Agrobacterium). After selection and/or screening, the protoplasts, cells, or plant parts (e.g., explants) that have been transformed can be regenerated into whole plants, using methods known in the art.
For transformation and regeneration of cereal crops, an embodiment of the present invention uses the principle of the binary vector system (Hoekema et al., Nature 303:179-180. 1983; and European Patent Application No. 0120516) in which Agrobacterium strains containing a vir plasmid with the virulence genes and a 5 compatible plasmid with the gene construct to be transferred. The binary vectors as used in this example contain, between the left- and right-border sequences of the T-DNA, an hph gene coding for hygromycin resistance and a multiple cloning site for insertion of gene constructs.
The promoter used for directing the expression of the phytase can be an 10 a-amylase gene promoter. The a-amylase gene promoters are active in germinating seeds (Huttly et al., EMBO J. 8:1907-1913, 1989; Skriver et al., Proc. Natl.
Acad.
Sci. USA 88:7266-7270, 1991; Lanahan et al. Plant Cell 4:203-21 l, 1992;
Tanida et al., Mol. Gen. Genet. 244:127-134, 1994; Itoh et al., Plant Physiol. 107:25-31, 1995), sucrose-starved suspension cells (Chan et al., J. Biol. Chem. 269:17635-15 17641, 1994), and other tissues and organs (Chan et al., Plant Mol. Biol.
22:491-506, 1993) of cereal crops.
The transgene can further includes a signal peptide sequence derived from the a-amylase genes or another gene that is capable of directing the recombinant proteins toward the endoplasmic reticulum, vacuole, protein body, or extracellular 20 space. Other regulatory sequences, such as terminator sequences and polyadenylation signals that function in plants, can be included in the transgene. An example of one such sequence is the 3' untranslated region of the nopaline synthase (Nos) gene ofAgrobacterium tumefaciens or the 3' untranslated region of a rice a-amylase gene (U.S. Patent No. 5,969,127).
25 Once a transgenic plant of the invention is produced, expression in tissues other than a seed tissue can be beneficial. For example; the transgenic plant can be used as a producer of a recombinant phytase, whether the phytase is isolated from a leaf, sheath, stem, or root of the transgenic plant.
Phytase activity can be measured using any method known in the art, 30 including ELISA, Western blotting, and direct enzyme assays using colorimetric techniques or native gel assays. See e.g., Shimizu, Biosci. Biotech. Biochem.
56:1266-1269, 1992; Yanke et al., Microbiology 144:1565-1573, 1998; and Kim et al., Enzyme Microb. Technol. 22:2-7, 1998.
The transgenic plants, plant organs, or malted seeds can be used directly, i.e., without further processing, or can first be processed via conventional means such as grinding to a consistency suitable for a particular use. Alternatively, the phytase can be extracted from the plant, plant organ, or malted seeds and, if desired, purified before use using conventional extraction methods and purification techniques.
See, e.g.; Laboure et al., Biochem. J. 295:413-419, 1993; and Golovan et al., Can.
J.
Microbiol. 46:59-71, 2000.
Without further elaboration, it is believed that one skilled in the art can, based on the above disclosure, and the production of transgenic plants and seeds as described below, utilize the present invention to its fullest extent. The following examples are to be construed as merely illustrative of how one skilled in the art can isolate and use the transgenic plants of the invention, and are not limitative of the remainder of the disclosure in any way. Any publications, patents, or patent applications cited in this disclosure are hereby incorporated by reference.
ny a r~rnr ~ ~
The methods, materials, and procedures used in the present example are first described.
Methods and Materials Plant Material. The rice variety used in this example was Oryza sativa L.
cv. Tainung 67. Immature seeds were dehulled, sterilized with 2.4% NaOCI for 1 hour, washed extensively with sterile water, and placed on N6D agar medium for callus induction as described in Toki, Plant Mol. biol. Rep. 15:16-21, 1997.
After one month, calli derived from scutellae were subcultured in fresh N6D medium for transformation or in a liquid MS medium containing 3% sucrose and 10 pM 2,4-D
to establish a suspension cell culture as previously described in Yu et al., J. Biol.
Chem. 266:21131-21137, 1991.
Plasmids. Plasmid aAmyB-C carries a 1.4-kb rice a-amylase cDNA insert in pBluescript KS+ (Stratagene) (Yu et al., Gene 122:247-253, 1992). Plasmid pRYl8 carries a 3.8 kb DNA fragment that contains a rice genomic rDNA cluster, including the 3' halfportion of 18S rRNA gene, the complete 5.85 rRNA gene, and 5 the 5' half portion of the 25S rRNA gene in pUCl3 (Sano et al., Genome 33:209-218, 1990). Plasmid RAMYG6a contains the 3' half portion and 3' flanking region of aAmy8 genomic DNA and was generated from screening a rice genomic DNA
library (Clontech) using aAmyB-C as a probe. The selected clone was subsequently subcloned from a positive EMBL-3 phage clone into pBluescript (Stratagene).
10 Plasmid RAMYG 17 contains the 5' flanking region, the entire coding region, and the 3' flanking region of aAmy7 genomic DNA and was generated from screening a rice genomic DNA library (Clontech) using aAmyB-C as a probe. Further details regarding RAMYG6a and RAMYG17 can be found in Ho et al., Master's Thesis, Department of Biology, National Taiwan Normal University, 1991. The selected 15 clone was subsequently subcloned from a positive EMBL-3 phage clone into pBluescript.
Plasmid Construction. The 5' end of the S. ruminantium phytase gene (SrPf~ was modified by PCR using the plasmid pSrPf6 (U.S. Patent No.
5,939,303) as a DNA template and the primers 5'-TTAAGCGATATCGCCAA
20 GGCCCCGGAACAGA-3' (SEQ ID NO:1; EcoRV site underlined) and 5'-ACGCAGGATCCACCTCATAAAACC-3' (SEQ ID N0:2; BamHI site underlined) to yield a recombinant gene in which an EcoRV site was incorporated immediately 5' to the codon (bolded in SEQ ID NO:1 ) specifying the first amino acid of the mature, processed phytase enzyme and a BamHI site at the end of the 25 phytase gene. The EcoRV site allows for the fusion of the phytase gene to the signal peptide sequence of the a-amylase gene aAmyB.~ The PCR product was subcloned into the EcoRV and BamHI sites of pBluescript (Stratagene) to generated pBS/SrPf6.
The E. coli phosphatase gene appA was similarly modified by PCR at the 5' 30 and 3' ends using plasmid pET-appA (Golovan et al., Can. J. Microbiol.
46:59-71, 2000) as a DNA template and the oligonucleotides 5'-ACGGCGGATATCCAGAGTGAGCCGG AGCTGA-3' (SEQ ID N0:3; EcoRV site underlined) and S'-AGGTTGGATCCTTACA AACTGCACGAAGG GT-3' (SEQ
ID N0:4; BamHI site underlined). The resulting PCR product was subcloned into pBluescript to generate pBS/appA.
A 1.2 kb promoter and signal peptide region of aAmy8 was excised with SaII
and Hi~zdIII from pAG8 (Chan et al., Plant Mol. Biol. 22:491-506, 1993) and subcloned into pBluescript to generated pBS/BSP. The aAnzy8 3'untranslated region (3'UTR) was PCR-amplified using RAi~IYG6a as the DNA template and the 10 oligonucleotides 5'-CG GGATCCTAGCTTTAGCTATAGCGAT-3' (SEQ ID NO:S;
BamHI site underlined) and 5'-TCCCCGCGGGTCCTCTAAGTGAACCGT-3' (SEQ ID N0:6; SacII underlined). The nopaline synthase gene (Nos) 3'UTRs was PCR-amplified using pBI221 (Clontech) as the DNA template and the oligonucleotides 5'-TCCGGATCCCAGATCGTTCAAAC ATTT-3' (SEQ ID N0:7;
15 BamHI site underlined) and 5'-AGCCCGCGGGATCGATCTA GTAACAT-3' (SEQ
ID N0:8; SacII underlined).
The aAmy8 and Nos 3'UTRs were subcloned into the BamHI and SacII sites in pBS/8SP to generate pBS/8SP8U and pBS/8SPNos, respectively. The SrPf6 was excised with EcoRV and BamHI from pBS/SrPf6 and subcloned into the same sites 20 in pBS/8SP8U and pBS/8SPNos to generate pBS/8F8U and pBS/BFN, respectively.
The appA gene was excised with EcoRV and BamHI from pBS/appA and subcloned into the same sites in pBS/8SP8U and pBS/BSPNos to generate pBS/8A8U, and pBS/BAN. The correct in-frame fusion of the aAnry8 signal peptide sequence with the SrPf6 or appA coding region, and the junction regions which link the SrPf6 or 25 appA coding region with the aAmy8 3'UTR or Nos 3'UTR were all verified by DNA sequencing.
The 1.7-kb promoter and signal peptide region of aAmy7 was PCR-amplified using RAMYGI7a as a DNA template and the oligonucleotides 5'-ACCGGGTCGAC GTATACATGTCACCTACA-3' (SEQ ID N0:9; SaII site 30 underlined) and 5'-GGTGATATCCAGGACTT GCCCGGCTGT-3' (SEQ ID
NO:10; EcoRV site underlined) to yield a PCR product having a SaII site at the 5' end of the aAnZy7 promoter and an EcoRV site immediately 3' to the signal peptide sequence. The PCR product was subcloned into the SaII and EcoRV sites in pBluescript to generate pBS/7SP. The aAmy7 3'UTR was PCR-amplified using RAMYG17 as the DNA template and the oligonucleotides 5'-GCTCTAGAAATCTGAGCGCACGATG-3' (SEQ ID NO:11; XbaI site underlined) 5'-TCCCCGCGGTAAGCATTAAGCAGTGCA-3'(SEQ ID N0:12; SacII site underlined. The PCR product was subcloned into the XbaI and SacII sites in pBS/7SP to generate pBS/7SP7U. The Nos 3'UTR was excised withXbaI and SacII
10 from pBS/BSPN and subcloned into the same sites in pBS/7SP to generate pBS/7SPNos. The SrPfG gene was excised with EcoRV and BamHI from pBS/SrPf6 and subcloned into the same sites in pBS/7SP7U and pBS/7SPNos to generate pBS/7F7U and , pBS/7FN, respectively. The appA gene was excised with EcoRV
and BamHI from pBS/appA and subcloned into the same sites in pBS/7SP7U and 15 pBS/7SPNos to generate pBS/7A7U and pBS/7AN, respectively. The correct in-frame fusion of the aAmy7 signal peptide sequence with the SrPf6 or appA
coding region, and the junction regions which link the SrPf6 or appA coding region with the aAmy7 3'UTR or Nos 3'UTR are all verified by DNA sequencing.
The cauliflower mosaic virus 35S RNA (CaMV35S) promoter-hygromycin 20 B phosphotransferase (hph) coding sequence-tumor morphology large gene 3'UTR
(tml) fusion gene was excised with EcoRI from pTRA 1 S 1 (Zheng et al., Plant Physiol. 97:832-835, 1991) and subcloned into the EcoRI site of the binary vector pPZP200 (Hajdukiewicz et al., Plant Mol. Biol. 25:989-994, 1994) to generate pPZP/HPH. pPZP/HPH was linearized with SaII and blunted-ended to served as a 25 vector for cloning. pBS/8F8U, pBS/BFN, pBS/8A8U, pBS/8AN, pBS/7F7U, pBS/7FN, pBS/7A7U, and pBS/7AN were lineanzed with PvuII to serve as inserts for cloning. The inserts were ligated with the vector to generate pPZP/8F8U, pPZP/8FN, pPZP/8A8U, pPZP/BAN, pPZP/7F7U, pPZP/7FN, pPZP/7A7U, and pPZP/7AN, respectively.
Rice Transformation. Plasmids were introduced into Agrobacteriz~m tumefaciens strain EHA101 (Hood et al., J. Bacteriol. 168:1291-1301, 1986) with an electroporator (BTX) following the manufacturer's instruction. Calli induced from immature rice seeds were co-cultured with Agrobacterium according to the methods described by Hiei et al., Plant J. 6:271-282, 1994 and Toki et al., supra.
Northern Blot Analysis. Total RNA was isolated from endosperms of germinating seeds as described in Yu et al., Plant Mol. Biol. 30:1277-1289, 1996 and isolated from cultured suspension cells using a TRIZOL reagent (GIBCO BRL).
RNA gel blot analysis was performed as described in Thomas, Methods Enzymol.
100:255-266, 1983. Briefly, 10 ~g of total RNA was electrophoresed on a 1%
agarose gel containing 10 mM sodium phosphate buffer (pH 6.5), transferred to a nylon filter, and hybridized with 32P random primer labeled SrPf6 DNA, appA
DNA, czAmyB gene-specific DNA, or rDNA probe. The aAmy8 gene-specific DNA was prepared as described in Sheu et al., J. Biol: Chem. 271:26998-27004, 1996.
The blot was visualized using autoradiography and quantified using software accompanying the of a PhosphoImager (Molecular Dynamics).
Western Blot Analysis. Total proteins were extracted from endosperms of germinating seeds using an extraction buffer (SO mM Tris-HCl [pH 8.8], 1 mM
EDTA, 10% glycerol, 1% Triton X-100, 10 mM (3-mercaptoethanol, and 0.1%
sarkosyl). Western blot analysis was performed as described by Yu et al., J.
Biol.
Chem. 266:21131-21137, 1991.
Phytase Activity Assay. Protein extract was prepared from the germinating seeds as described by Li et al., Plant Physiol. 114:1103-1111, 1997. The phytase activity was determined as described in Shimizu, Biosci. Biotech. Biochem.
56:1266-1269, 1992.
Results The aAmy8 promoter confers sucrose starvation-enhanced accumulation of appA and SrPf6 mRNAs in transformed rice suspension cells. To determine whether the crAmy8 promoter controls sugar-dependent expression of appA in rice, a 1.2-kb DNA fragment containing the 5' regulatory and signal peptide sequences of aAmyB
was fused in-frame at the S' end of the appA or SrPf6 gene. The chimeric gene was inserted into a binary vector and introduced into Agrobacterium for rice transformation. Many transformed cell lines were obtained and eight lines were selected for further study. The transformed calli were cultured as suspension cells, and the suspension cells were then cultured in medium with or without sucrose.
Total RNA was purified and subjected to gel blot analysis using appA DNA, SrPf6 DNA, crAmy8 gene-specific DNA, or rDNA as a probe. Accumulation of appA, SrPf6, and aAmy8 mRNAs were detectable in cells starved of sucrose but not in cells provided with sucrose. No appA or SrPf6 mRNA was detected in the non-transformed (NT) cells.
The aAmy8 promoter confers sucrose starvation-enhanced activity of phytase in transformed rice suspension cells. To determine whether the transformed rice suspension cells carrying an aAmyB-appA or aAmyB-SrPf6 chimeric gene synthesize and secrete phytase into the culture medium, the phytase activity in 15 suspension cells and in culture medium were determined. The phytase activity was detectable in the transformed cells and in the culture medium. In both cases, phytase activity was significantly enhanced by sucrose starvation. The phytase activity was also detectable in the non-transformed cells under sucrose starvation, which was probably caused by the endogenous phytase gene.
The aAmy7 and aAmy8 promoters control expression of SrPf6 in germinating transgenic rice seed. Transgenic rice plants were regenerated from the transformed rice calli carrying aAmy7-SrPf6 or crAmyB-SrPf6. The T1 seeds of some transgenic lines were randomly selected for further study. To determine the role of the aAmy7 and aAmyB promoters in the expression of appA and SrPf6 genes during seed germination, the transgenic rice seeds were germinated for 5 days.
Total RNA was purified from the entire germinated seed (including the shoots, roots, and endosperms) and subjected to gel-blot analysis using SrPf6 DNA, crAmyB gene-specific DNA, or rDNA as a probe. Under the control of czAmy7 promoter, expression of SrPf6 could be detected in some of the germinated seeds. Under the control of aAmyB promoter, expression of SrPf6 could be detected in all the germinated seeds. No SrPfG mRNA was detected in non-transformants.
The aAmy8 promoters control expression of appA ira germinating transgenic rice seed. Transgenic rice plants were regenerated from the rice calli carrying 5 aAmyB-appA. The T1 seeds of some transgenic lines were randomly selected for further study. Seeds were germinated for 5 days and total RNA was purified from the entire germinated seeds (including the shoots, roots, and endosperms) and subjected to gel-blot analysis using appA DNA, aAmy8 gene-specific DNA, or rDNA as a probe. Under the control of the aAmy8 promoter, expression of appA
could be detected in all germinated seeds. No appA mRNA was detected in the non-transformants.
The aAnZy8 promoter confers high phytase activity in germinating transgenic rice seeds. To determine the expression level of phytase in germinated transgenic seeds, phytase activity in the T1 transgenic seeds were analyzed. The transgenic rice 15 seeds were germinated for 5 days. Cell extract was prepared from the entire germinated seeds (including the shoots, roots, and endosperms) and subjected to phytase activity analysis. Phytase activity was higher in all the germinated transgenic seeds carrying the aAmyB-SrPf6-Nos chimeric gene than in the non-transformants. One of the transgenic lines, 8FN-8, had significantly higher phytase activity as compared with other transgenic lines. Phytase activity was higher in all the germinated transgenic seeds carrying the aAmyB-appA chimeric gene than in the non-transformant. One transgenic line, 8AN-14 had significantly higher phytase activity as compared with other transgenic lines including 8FN-8.
The introduced phytase and acid phosphatase genes are inherited to the progenies of transgenic rice. To determine whether the introduced appA and SrPf6 DNAs were inherited to the progenies of Tl transgenic rice, the T2 seeds of transgenic lines 8AN-14 and 8FN-8 were germinated for 5 days. Total RNA was purified from the entire germinated seeds and subjected to gel blot analysis using appA DNA, SrPf6 DNA, or rDNA as a probe. Expression of appA and SrPf6 was 30 detected in most of the germinated T2 seeds.
The aAmy8 promoter confers temporal expression of phytase in germinating transgenic rice seed. To determine the expression pattern of phytase in germinated transgenic rice seed carrying aAmyB-appA or aAmyB-SrPf6, the T2 seeds of transgenic lines 8FN-8-8 and 8AN-14-10 were germinated for various lengths of time, and phytase activity was determined. The phytase activity in the transgenic seeds increased as germination proceeded and reached a peak at days 5-6 while declining afterwards. Phytase activity was also detectable in the non-transformed seeds, but remained at low level throughout the entire germination period.
The molecular weight of phytase produced in germinating transgenic rice seeds is similar to that produced in Pichia pastoris. SrPf6 was cloned into a plasmid under the control of the glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter and overexpressed in Pichia pastoris. The SrPf6 cDNA was PCR-amplified using pSrPf6 as the DNA template and oligonucleotides 5' -CGGAATTCGCCAAGGCGCCGGAGC AGAC-3' (SEQ ID N0:25) (EcoRI site underlined) as S' primer and 5' -GCTCTAGATACGCCTTC GCCGGATGGCT-3' (SEQ )D N0:26) (Xbal site underlined) as 3' primer. The DNA fragment containing SrPf6 cDNA was digested with EcoRI and Xbal and ligated into the same sites in pGAPZaA (Invitrogen) to generate pGAP-SrPf6. SrPf6 was led by a signal peptide a-factor and was under the control of GAP promoter. pGAP-SrPf6 was linearized by restriction enzyme AvrII and transferred into P. pastoris host strain SMD
1168H by electroporation. The transformed cells were plated on YPDS (1% yeast extract, 2%
peptone, 2% dextrose, 1 M sorbitol, pH 7.5) plus zeocin (100 mg/ml) at 30°C for 3 days. Production and purification of phytase were performed according to the manufacturer's instruction provided with pGAPZaA.
To compare the molecular weight of phytase produced in germinating transgenic rice seeds with that of the phytase overexpressed in Pichia, seeds of transgenic rice line 8FN-8 were germinated for 5 days. Total proteins were extracted from the entire germinated seeds and subjected to Western blot analysis using phytase polyclonal antibodies. The full-length cDNA of SrPf6 was PCR-amplified using plasmid pSrPf6 as DNA template and oligonucleotides 5'-CCCGAATTCATGAAATACTGGCAG-3' (SEQ ID N0:27) (EcoRI site underlined) as 5' -primer and 5' -CCCGAGCTCTTACGCCTTCGCCGG-3' (SEQ ID N0:28) (SacI site underlined) as 3' primer. The amplified DNA fragment was digested with EcoRI and SacI and ligated into the same sites in pET20b(+) (Novagen) to generate pET-SrPf6. pET-SrPf6 was transferred to E. coli strain BL21 (DE3) and expressed.
Purification of phytase was performed according to the instruction provided by Novagen. One hundred micrograms of purified phytase was injected into a New Zealand White rabbit successively at 4-6 week interval according to the methods generally described in Williams et al., "Expression of foreign proteins in E.
coli using plasmid vectors and purification of specific polyclonal antibodies," In: DNA
Cloning 2. Expression Systems: A Practical Approach, Glover et al., eds., IRL Press, New York, 1995.
The molecular weight of the full-length phytase produced by germinating transgenic seeds was similar to that produced by Pichia. It was known that the phytase encoded by SrPf6 had a molecular weight of 36.5 kD when expressed in E.
coli (U.S. Patent No. 5,939,303). The molecular weight of phytase expressed in Pichia was about 36.5 kD and 38 kD. Similarly, when the phytase was expressed in transgenic rice seeds the molecular weight was about 36.5 kD and 40 kD. It was known that there is one potential glycosylation site in the primary structure of SrPf6 (U.S. Patent No. 5,939,303). The 38 kD and 40 kD phytases expressed in Pichia and transgenic rice seeds, respectively, were probably caused by differential glycosylation. One protein with molecular weight of 34 kD was also present in the germinating rice seeds, which could have been a degradation product of the phytase.
These results indicate that the mature phytase produced in the transgenic plants and seeds described herein were properly post-translationally modified.
Transgenic germinated rice seedlseedling contained phytase with high specific activity and broad pHprofiles for high activity. Unexpectedly, it was also discovered that the phytase specific activity expressed in the germinated transgenic seeds is two fold higher than that expressed in E. coli. The reason for this surprising result could be that there are many endogenous hydrolytic enzymes simultaneously expressed in the germinated seeds. These hydrolytic enzymes may have a synergistic effect on the phytase activity present in germinating seeds.
Alternatively, or in conjunction, the post-translationally modified phytase in the germinating seeds may have increased the enzyme's specific activity, which resulted in the observed increase in phytase activity. Thus, besides the advantages of expressing phytase in transgenic malted seeds, the specific activity of the recombinantly produced enzyme was also increased.
The ruminal bacterial phytase has a pH optimum of 4.0-5.5 (U.S. Patent No. 5,939,303). To determine the optimal pH of phytase expressed in the rice seeds described above, T2 seeds of three transgenic rice lines were germinated for 5 days, 10 and the optimal pH for phytase expressed in rice germinated seed/seedling was determined. The results showed that the activity of phytase expressed in all three transgenic rice lines was optimal at pH 3 and pH 4.5-5.0 (Fig. 1). In the digestive tract of monogastric animals, the pH ranges from 2-3 in the stomach and 4-7 in the small intestine. The broader and more acidic optimal pH profile of phytase expressed in rice allows the enzyme to function well in the stomach and small intestine of animals and is therefore an advantage for its use as a feed additive. The reason for this surprising result could be that the phytase expressed in rice was post-translationally modified, which resulted in the increase in activity and/or stability over a broad range of pH.
20 The E. coli acid phosphatase has a pH optimum of 2.5 (Dassa et al., J.
Biol.
Chem. 257:6669-6676, 1982; and Dassa et al., J. Bacteriol. 172:5497-5500, 1990).
To determine the optimal pH of acid phosphatase expressed in rice, T2 seeds of transgenic rice line 8AN-14-6 were germinated for 5 days, and the optimal pH
for phytase expressed in germinated rice seed/seedling was determined. The results 25 show that activity of acid phosphatase expressed in rice was optimal over a pH range of 3-5.5 (Fig, 2) . As with the ruminal bacterial phytase expressed in rice, the broader and more acid optimal pH profile of E. coli acid phosphatase would allow the enzyme to function well in the stomach and small intestine of animals and is therefore an advantage for its use as a feed additive. The reason for this surprising 30 result also could be that the acid phosphatase expressed in rice was post-translationally modified, which resulted in increase in activity and/or stability over a broad range of pH.
~~r a r~rpr ~ ~
The methods, materials, and procedures used in the present example are first described.
Materials and Methods Plant Material. All pant materials were prepared as described in Example 1.
Preparation of genomic DNA. Rice seeds were germinated and grown in the dark for 1 week. Bacteria T. ethanolicus 39E was obtained from the American Type Culture Collection (ATCC 53033). The bacterial and rice genomic DNA was purified according to the method described in Sheu et al., J. Biol. Chem 271:26998-27004, 1996.
PCR. The 1351-by glutelin gene promoter region (Fragment I; Zheng et al., Plant J. 4:357-366, 1993; and Wu et al., Plant Cell Physiol. 39:885-889, 1998) was PCR-amplified using rice genomic DNA as template and primers B1-5 (5'-GGGGAATTCGA TCTCGATTTTTGAGGAAT-3' [SEQ ID N0:13], EcoRI site underlined) and B 1-3 (5'-GGGGGATCCCATAGCTATTTGTACTTGCT-3' [SEQ ID
N0:14], BamHI site underlined). The glutelin gene promoter plus 75-by putative signal peptide sequence (Fragment II) was PCR-amplified using rice genomic DNA
as template and primers B1-5 and B1-sp (5'GGGGGATCCGGGATTAAATAGCTGGGCCA-3' [SEQ ID N0:15], BamHI
site underlined). The glutelin gene promoter plus putative signal peptide and propeptide sequences (Fragment III) was PCR-amplified using rice genomic DNA
as template and primers B1-5 and B1-pro (5'GGGGGATCCCCTCACTTTCCGAAG TGGTT-3' [SEQ ID N0:16], BamHI
site underlined).
The truncated apu ORF encoding only amino acid 75 to 1029 was PCR-amplified using the genomic DNA of T. ethanolicus 39E as template and oligonucleotides 5'-CGG GATCCTTAAGCTTGCATCTTGA-3' (SEQ ID N0:17;
BamHI site underlined) as forward primer and 5'-CCGGCGGCCGCCTACATATTTTCCCCTTGGCCA-3' (SEQ ID N0:18; NotI site underlined) as reverse primer.
Plasmid construction. The PCR-amplified Fragments I, II, and III were 5 digested with EcoRI and BamHI and subcloned into the same sites in pBluescript (Stratagene) to generate pBS-G, pBS-Gp, and pBS-Gpp, respectively. The truncated apu was digested with BamHI and NotI and fused downstream of the GIuB-1 promoter, GIuB-1 promoter-signal peptide sequence, and GIuB-1 promoter-signal peptide-propeptide sequence in pBS-G, pBS-Gp, and pBS-Gpp, respectively, to 10 make translational fusions and to generate plasmids pBS-G-apu, pBS-Gp-apu, and pBS-Gpp-apu, respectively. The nopaline synthase gene (Nos) 3' untranslated (UTR) was PCR-amplified using pBI221 (Clontech) as DNA template and oligonucleotide 5'-TCCGAGCTCCAGATCGTTC AAACATTT-3' (SEQ ID
N0:19; SacI site underlined) as forward primer and oligonucleotide 5'-15 AGCGAGCTCGATCGATCTAGTAACAT-3' (SEQ ID N0:20; SacI underlined) site as reverse primer. The Nos 3'UTR was digested with SacI and fused downstream of apai in pBS-G-apu, pBS-Gp-apu, and pBS-Gpp-apu to generate pBS-G-apu-Nos, pBS-Gp-apu-Nos, and pBS-Gpp-apu-Nos, respectively.
The 1.2 kb promoter and signal peptide sequence of crAmy8 was excised with 20 SalI and HindIII from pAG8 (Chan et al., Plant Mol. Biol. 22:491-506, 1993) and subcloned into pBluescript to generate pBS/8sp. The aAmy8 3'UTRs was PCR-amplified using RAMYG6a as a DNA template and oligonucleotide 5'-CGCCGCGGTAGCTTTA GCTATAGCGAT-3' (SEQ ID N0:21; SacII site underlined) as forward primer and oligonucleotide 5'-25 TCCCCGCGGGTCCTCTAAGTGAACCGT-3' (SEQ ID N0:22; SacII site underlined) as reverse primer. Plasmid RAMYG6a contains the 3' half portion of the coding sequence and 3' flanking region of aAmy8 genomic DNA and was generated by screening of a rice genomic DNA library (Clontech) using crAmyB-C
(Yu et al., Gene 122:247-253, 1992) as a probe. The aAmyB 3'UTRs was subcloned 30 into the SacII sites in pBS/8sp to generate pBS/8sp8U. The truncated apu was cut with BamHI and NotI and subcloned into the same sites in pBS-8sp8U to generate pBS-aAmyB-sp-apu-8U.
The 1.1-kb promoter and signal peptide sequence of aAmy3 was excised with SaII and HindIII from p3G-132II (Lu et al., J. Biol. Chem. 273:10120-10131, 1998) and subcloned into pBluescript to generate pBS-asp. The aAmy3 3'UTR was excised with HindIII and SacI from pMTC37 (Chan et al., Plant J. 15:685-696, 1998) and subcloned into the same sites in pBS-asp to generate pBS-3sp3U. The truncated apu was digested with BamHI and NotI and subcloned into the same sites in pBS-3sp3U to generate pBS-aAmy3-sp-apu-3U.
10 The correct in-frame fusion of the GIuB, aAnry3, and aAmy8 signal peptide or propeptide sequence with the apu coding region, the junction regions which link the apu coding region with the aAmy3, aAnzyB, or Nos 3'UTR were all verified by DNA sequencing. The GIuB-apu-Nos, GIuB-sp-apu-Nos, GIuB-spp-apu-Nos, aAmy3-sp-apu-aAmy3 3'UTR, and aAmyB-sp-apu-aAmy8 3'UTR chimeric genes were excised from pBS-G-apu-Nos, pBS-Gp-apu-Nos, pBS-Gpp-apu-Nos, pBS-aAmy3-sp-apu-3U, and pBS-aAmyB-sp-apu-8U with SaII, blunt-ended, and inserted into the HindIII-digested and blunt-ended binary vector pSMYIH (Ho et al., Plant Physiol. 122:57-66, 2000) to generate pSMYI/Gapu, pSMYl/Gpapu, pSMYI/Gppapu, and pSMYI/3apu and pSMYI/8apu, respectively.
Transformation. Transformations were carried out as described in Example 1.
Expression of APU in E. coli and preparation of antibodies. The truncated apu encoding amino acids 75 to 1029 was PCR-amplified using genomic DNA of T.
ethanolicz~s 39E as template and oligonucleotides 5'-CGCATATGTTAAGCTTGC
25 ATCTTGATTC-3' (SEQ ID N0:23; NdeI site underlined) as forward primer and 5'-CCGCTCGAGCTACATATTTTCCCCTTGGCCA-3' (SEQ ID N0:24; XhoI site underlined) as reverse primer. The amplified DNA fragment was digested with NdeI
and XhoI and ligated into the same sites in pET20b(+) (Novagen) to generate pET-APU. pET-APU was transferred to E. coli strain BL21 (DE3), and APU was 30 expressed. Purification of APU was performed according to the instruction provided by Novagen. One hundred micrograms of purified APU was injected into a New Zealand White rabbit successively at 4-6 week interval according to the methods described in Williams et al., supra.
APU activity assay and enzyme-linked imnzzmosorbent assay (ELISA). Rice seeds or tissues were ground in liquid N2, lysed with a buffer (90.8 mM
KZHP04, 9.2 mM KH~P04, 10 mM EDTA, 10% glycerol, 1% Triton X-100, and 7 mM (3-mercaptoethanol) and centrifuged at 15,000 X g for 10 minutes. The supernatant was then collected. APU activity was assayed as described in Mathupala et al., J.
Biol. Chem. 268:16332-16344, 1993. ELISA was perfornled as described in Ausubel et al., Short Protocols in Molecular Biology, 2nd ed., In: A
Compendium of Methods from Current Protocols in Molecular Biology, John Wiley & Sons, New York, 1992. The total protein concentration was determined using a Bio-Rad protein assay kit based on the dye binding assay of Bradford (Bradford, Anal. Biochem.
72:248-254, 1976).
Determination of sugar concentration. Mature rice seeds were ground to powder with a mortar and pestle. Rice seedlings were ground to powder in liquid NZ
with mortar and pestle. Water was added to the powder to make a 10% (w/v) slurry.
The slurry derived from mature rice seeds was heated at 90°C for 30 minutes, total soluble sugars were extracted, and the concentration of sugars was determined as described in Chen et al., Plant J. 6:625-636, 1994. The slurry derived from rice seedlings was heated at 85°C for 2 hours, total soluble sugars were extracted, and the concentrations of glucose, fructose, sucrose, maltose, and maltotriose were determined by high-performance liquid chromatography (HPLC) as described in Shaw et al., Biosci. Biotech. Biochem. 56:1071-1073, 1992.
Results Isolation of the rice glutelin gene promoter, signal peptide, and propeptide sequences. Primers based on the nucleotide sequence of a glutelin gene (GIuB-1 ) (Takaiwa et al., Plant Mol. Biol. 17:875-885, 1991) were designed, and three DNA
fragments containing the GIuB-I promoter, putative signal peptide sequence, and putative propeptide sequence were synthesized using PCR. The putative 25-amino acid signal peptide cleavage site was predicted based on a statistical method (von Heijne, J. Mol. Biol. 184:99-105, 1985). The putative 36-amino acid propeptide cleavage site was predicted based on the sweet potato sporamin propeptide sequence (Matsuoka et al., Proc. Natl. Acad. Sci. USA 88:834-838, 1991). Fragment I
contained the 1351 by GluB-I promoter region ending right at the translation initiation codon. Fragment II contained Fragment I plus a 75 by signal peptide sequence. Fragment III contained Fragment II plus a 108 by putative propeptide sequence. The purpose for including the signal peptide or propeptide region was to target APU to different cellular compartments (e.g., cytoplasm, protein body, or vacuole). Effect of cellular localization on yield, stability, and activity of APU in transgenic rice seeds could then be compared. Transformed rice suspension cells expressed and secreted APU into the culture medium.
Transformed rice suspension cells expressed and secreted APU into the culture medium. All plasmids were delivered into rice calli by particle 15 bombardment or Agrobacterium-mediated transformation systems. The transfected rice calli were grown under hygromycin selection. Genomic Southern blot analyses of the transformed cell lines revealed that, in general, the transgenic lines obtained via the Agrobacterium-mediated transformation contained 1 to 2 copies and that, via the particle bombardment, the transgenic plants contained multiple copies (more than 2) of the apu gene in the genomes.
The transformed rice calli were cultured in liquid MS medium to generate suspension cell culture. Because APU was expressed with signal peptide or propeptide sequence in most of the transgenic lines, the culture media were collected for analysis of APU accumulation. The amount of APU in the media of transformed rice suspension cell cultures was determined using ELISA and the purified E.
coli-expressed APU as a standard. As shown in Fig. 3, the amount of APU in media of _ transformed suspension cells was significantly higher than that in media of non-transformed cells. In media of cells carrying aAmy3 or aAmy8 promoters, the amount of APU was higher in the absence of sucrose than in the presence of sucrose.
Surprisingly, although the GIuB-I promoter had been shown to confer endosperm-specific expression in developing rice seeds, it was found that APU
was also expressed in cultured rice suspension cells. In media of cells carrying the GIuB-1 promoter, the amount of APU was higher in the presence of sucrose than in the absence of sucrose. Additionally, APU expressed without a signal peptide sequence was also present in the culture media. Computer analysis indicated that the N-terminal of APU had amino acid sequence features resembling a signal peptide sequence, which might explain the secretion of APU into the culture medium without a leader peptide added. Thus, it was discovered that APU without a signal peptide sequence could be secreted into the culture medium.
Transgenic germinated rice seedlseedling contains high level ofAPU.
Transgenic calli carrying apu under the control of an a-amylase or glutelin gene promoter and with or without signal peptide sequence were regenerated. These transgenic plants were self fertilized for two generations, and the T2 homozygous seeds were obtained.
15 Homozygosity of transgenic seeds was determined by germination of 25 transgenic seeds in water containing 50 pg/ml hygromycin for 7 days, and then calculating the ratio between numbers of growing and non-growing seeds.
Homozygous seeds was expected to germinate and grow under hygromycin treatment. Five T2 homozygous seeds from each transgenic rice line carrying 20 various constructs were germinated and grown for S days. The entire germinated seeds/seedlings were collected, and the APU levels in cell extracts were determined using ELISA and purified E. coli-expressed APU as a standard. The average APU
level expressed under the control of either an a-amylase or glutelin gene promoter was higher than that of the non-transformants (Fig. 4). The expression of APU
in 25 germinated rice seed/seedling was unexpected, because it was known that the GIuB-I promoter was expressed specifically in endosperm during the development of the seed.
Transgenic matLrre rice seeds contain high levels ofAPU. Five T2 homozygous seeds of each transgenic rice line carrying a transgene were selected for 30 APU analysis. The embryo and endosperm of mature seeds were separately collected and homogenized in buffer to form an extract. APU levels in cell extracts were determined using ELISA. The average APU level expressed under the control of either an a,-amylase or glutelin gene promoter in transgenic seeds was higher than that in the non-transformed seed (Fig. 5). Unexpectedly, the GIuB-1 promoter 5 conferred APU expression in embryo. Additionally, the fact that crAmy3 and crAnry8 promoters conferred APU expression in embryo and endosperm of mature seed was also unexpected because it was known that a-amylase genes were expressed specifically in endosperm or transiently in embryo of germinating seed and not in the mature seed.
10 Trarasgenic germinated rice seedlseedling contains APU with high specific activity. The data in Fig. 4 indicated that the APU level was significantly higher in transgenic germinated seed/seedling than in the non-transformed control. To compare the specific activity of recombinant APU expressed in transgenic germinated seed/seedling, five T2 homozygous seeds of each transgenic rice lines 15 carrying various constructs were germinated and grown for 5 days. Cell extracts of the entire germinated seed/seedlings were prepared, and the APU level in the cell extract was determined using ELISA. APU activity per amount of APU in the cell extracts was determined after incubation of the cell extract at 90°C
for 30 minutes.
As shown in Fig. 6, the specific activity of APU present in transgenic germinated 20 seed/seedling varied from line to line regardless of the construct used.
Interestingly, the specific activity of APU expressed in transgenic germinated seed/seedling was two to seven fold higher than that of the E. coli-expressed APU. The reason for this surprising result could be that there are many endogenous hydrolytic enzymes present in the rice endosperm. These hydrolytic enzymes may have a synergistic 25 effect on the APU activity present in germinated seeds. Alternatively, or in conjunction, the post-translationally modified APU in the germinated seeds may have increased the enzyme's specific activity, which resulted in the observed increase in APU activity. Note that there are three potential glycosylation sites in the APU polypeptide, which may be differentially glycosylated depending on the 30 production method used. Thus, besides the above-mentioned advantages of expressing APU in transgenic germinated seeds, the specific activity of the recombinant enzyme was also increased.
Transgenic rice seed and germinated seedlseedling produce high level of sugars. The results summarized in Figs. 4 and 5 revealed that APU level is 5 significantly higher in transgenic mature seed and germinated seed/seedling, than in the non-transformed control. To determine whether transgenic seeds produce higher levels of soluble sugars than the non-transformants, five T2 homozygous seeds of each transgenic rice line carrying apu under the control of the GIuB-1 promoter were homogenized in water and incubated at 85°C for 2 hours. As shown in Fig. 7, the 10 concentration of soluble sugar in transgenic seed was higher than that in the non-transformed seed. Five T2 homozygous seeds of each transgenic rice line carrying apu under the control of crAmy3 and cz.Anry8 promoter were also homogenized in water and incubated at 90°C for 30 minutes. As shown in Fig. 8, the concentration of sugar in germinated seed/seedling was higher than that in the non-transformed 15 control. These results demonstrated that the increased level of APU in transgenic seed or germinated seed/seedling facilitated production of sugars from seed starch without addition of exogenous APU.
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT: ACADMIA SINICA
(ii) TITLE OF INVENTION: PROTEIN PRODUCTION IN TRANSGENIC PLANT
SEEDS
(iii) NUMBER OF SEQUENCES: 28 (iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: Swabey Ogilvy Renault (B) STREET: 1981 McGill College - Suite 1600 (C) CITY: Montreal (D) STATE: Quebec (E) COUNTRY: Canada (F) ZIP: H3A 2Y3 (v) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: PatentIn Release #1.0, Version #1.25 (vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER: CA 2,309,342 (B) FILING DATE: 2000-06-14 (C) CLASSIFICATION: AO1H-5/00 (vii) PRIOR APPLICATION DATA:
(A) APPLICATION NUMBER:
(B) FILING DATE:
(C) CLASSIFICATION:
(viii) ATTORNEY/AGENT INFORMATION:
(A) NAME: CAWTHORN, Christian (B) REGISTRATION NUMBER: 11005 (C) REFERENCE/DOCKET NUMBER: 6070-222 CC
(ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: (514) 847-4256 (B) TELEFAX: (514) 288-8389 (C) TELEX:
(2) INFORMATION FOR SEQ ID N0: 1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:
26a ttaagcgata tcgccaaggc cccggaacag a 31 (2) INFORMATION FOR SEQ ID NO: 2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 24 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:
acgcaggatc cacctcataa aacc 24 (2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:
acggcggata tccagagtga gccggagctg a 31 (2) INFORMATION FOR SEQ ID NO: 4:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 4:
aggttggatc cttacaaact gcacgaaggg t 31 (2) INFORMATION FOR SEQ ID NO: 5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 26b (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:
cgggatccta gctttagcta tagcgat 27 (2) INFORMATION FOR SEQ ID N0: 6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:
tccccgcggg tcctctaagt gaaccgt 27 (2) INFORMATION FOR SEQ ID N0: 7:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 7:
tccggatccc agatcgttca aacattt 27 (2) INFORMATION FOR SEQ ID NO: 8:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 26 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence 26c (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8:
agcccgcggg atcgatctag taacat 26 (2) INFORMATION FOR SEQ ID N0: 9:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:
accgggtcga cgtatacatg tcacctaca 29 (2) INFORMATION FOR SEQ ID N0: 10:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STR.ANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10:
ggtgatatcc aggacttgcc cggctgt 27 (2) INFORMATION FOR SEQ ID NO: 11:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 25 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11:
gctctagaaa tctgagcgca cgatg 25 26d (2) INFORMATION FOR SEQ ID N0: 12:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 12:
tccccgcggt aagcattaag cagtgca 27 (2) INFORMATION FOR SEQ ID NO: 13:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 13:
ggggaattcg atctcgattt ttgaggaat 29 (2) INFORMATION FOR SEQ ID N0: 14:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14:
gggggatccc atagctattt gtacttgct 29 (2) INFORMATION FOR SEQ ID NO: 15:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear 26e (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotidefor PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID
NO: 15:
gggggatccgggattaaata gctgggcca 29 (2) INFORMATION
FOR SEQ
ID N0:
16:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotidefor PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID
NO: 16:
gggggatcccctcactttcc gaagtggtt 29 (2) INFORMATION
FOR SEQ
ID N0:
17:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 25 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotidefor PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID
N0: 17:
cgggatccttaagcttgcat cttga 25 (2) INFORMATION
FOR SEQ
ID N0:
18:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 33 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotidefor PCR
26f (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18:
ccggcggccg cctacatatt ttccccttgg cca 33 (2) INFORMATION FOR SEQ ID NO: 19:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 19:
tccgagctcc agatcgttca aacattt 27 (2) INFORMATION FOR SEQ ID N0: 20:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 26 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20:
agcgagctcg atcgatctag taacat 26 (2) INFORMATION FOR SEQ ID N0: 21:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21:
cgccgcggta gctttagcta tagcgat 27 (2) INFORMATION FOR SEQ ID NO: 22:
(i) SEQUENCE CHARACTERISTICS:
26g (A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22:
tccccgcggg tcctctaagt gaaccgt 27 (2) INFORMATION FOR SEQ ID NO: 23:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23:
cgcatatgtt aagcttgcat cttgattc 28 (2) INFORMATION FOR SEQ ID NO: 24:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 24:
ccgctcgagc tacatatttt ccccttggcc a 31 (2) INFORMATION FOR SEQ ID N0: 25:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence 26h a (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25:
cggaattcgc caaggcgccg gagcagac 28 (2) INFORMATION FOR SEQ ID N0: 26:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 26:
gctctagata cgccttcgcc ggatggct 28 (2) INFORMATION FOR SEQ ID NO: 27:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 24 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 27:
cccgaattca tgaaatactg gcag 24 (2) INFORMATION FOR SEQ ID NO: 28:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 24 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 28:
cccgagctct tacgccttcg ccgg 24 26i
Background of the Invention The use of transgenic plants for the production of pharmaceutical proteins and industrial enzymes has been proposed. In general, expression of recombinant proteins relies on stable integration of a heterologous gene into a host plant genome using, e.g., Agrobacterium-mediated transformation or particle bombardment. In terms of cost, production of commercially valuable proteins using crops in the field is more competitive than other biological production systems (such as yeast, 10 bacteria, or mammalian cell cultures) which require complex and high-maintenance bioreactors. Further, protein production in plant can be easily scaled-up to produce large quantities.
Summary of the Invention 15 The invention is based on the discovery that hydrolytic enzymes have a specific activity higher than expected (as compared to, e.g., E. coli produced enzyme) when expressed in transgenic seeds using a transgene having a promoter active in a plant seed tissue and driving transcription of a sequence encoding the hydrolytic enzyme.
20 More specifically, the invention features a transgenic plant (e.g., a transgenic rice, barley, rye, or canola plant) whose genomic DNA includes a gene having a promoter (e.g., an a-amylase promoter, such as that of the aAmy8 gene, or a glutelin promoter) and a nucleotide sequence encoding a hydrolytic enzyme and operably linked to the promoter. The promoter drives expression of the hydrolytic enzyme in 25 a plant seed tissue of a developing seed, germinating seed, germinated seed, or seedling of the transgenic plant. The enzyme optionally hydrolyzes a substrate naturally occurring in a plant seed tissue. If the enzyme is a phytase, the enzyme can also be an acid phosphatase, such as the enzyme encoded by an appA gene, or a phytase from Selenomonas ruminantium (e.g., strain JY35, available as ATCC
30 55785), such as the enzyme encoded by the phyA gene. If the enzyme is a amylopullulanase (e.g., of Therrnoanaerobacter ethanolicus), the enzyme can also be an a-amylase. The invention also includes a transgenic seed produced from a transgenic plant as described above. As used herein, a "seed" can be a developing seed, a mature seed, a germinating seed, a germinated seed, or a seedling.
Thus, the 5 invention further features a method of producing a hydrolytic enzyme by providing a transgenic plant of the invention, harvesting a transgenic seed from the transgenic plant, germinating the seed, and optionally isolating the hydrolytic enzyme from the transgenic seed.
The invention also features a method of producing a polypeptide by 10 providing a transgenic plant whose genomic DNA contains a gene having an a-amylase promoter and a nucleotide sequence encoding a polypeptide and operably linked to the promoter; harvesting a transgenic seed from the transgenic plant;
germinating the transgenic seed to produce a mature seed; and isolating the polypeptide from the mature seed (e.g., from an embryo or endosperm tissue of the 15 mature seed). Also included in the invention is a method of producing a polypeptide by providing a transgenic plant whose genomic DNA contains a gene having a glutelin gene promoter and a nucleotide sequence encoding a polypeptide and operably linked to the promoter; harvesting a transgenic seed from the transgenic plant; germinating the transgenic seed; and isolating the polypeptide from an embryo 20 or endosperm tissue of the seed.
As used herein, a "phytase" is an enzyme that reacts with phytate or phytin to release phosphorus or a moiety that contains phosphorus that is absorbable in the GI
of a monogastric animal. Thus, a phosphatase that releases inorganic phosphorus or phosphate from phytate is also a phytase.
25 By one genetic element being "operably linked" to another is meant that one genetic element (either in a plus strand, minus strand, or double stranded form) is structurally configured to operate or affect another genetic element. For example, a promoter operably linked to a sequence encoding a polypeptide means that the promoter initiates transcription of a nucleic acid encoding the polypeptide.
Germination begins with water uptake by the seed (imbibition) and ends with the start of elongation by the embryonic axis, usually the radicle. Therefore, germination does not include seedling growth, which commences when germination terminates. For germination to be completed, the radicle must expand and penetrate 5 the surrounding structures. A developing seed is one that is germinating or supporting growth of the seedling. As used herein, the term "seedling" means the juvenile plant grown from a germinating seed, as defined in de Vogel, "The Seedling," In: Seedlings of Dicotyledons, Centre for Agricultural Publishing and Documentation, Wageningen, Netherlands, pp 9-25, 1983 An a-amylase gene promoter and signal peptide sequence can be fused upstream of the enzyme open reading frame (ORF) or gene, which can be derived from various sources. The chimeric gene is then introduced into a plant (e.g., cereal) genome. For example, a malted transgenic cereal grain that produces high levels of phytase can be used for human consumption, animal feed, or food processing.
Malting is the process by which grains are germinated under controlled condition and in contained facilities to produce a consistent product.
The advantages of using transgenic malted seeds to produce a hydrolytic enzyme as feed include: (1) the seeds contain a large quantity of nutrient and minerals in an easily available form that is easily transportable and not readily 20 perishable; (2) the nutrients in the seeds are not chelated by, e.g., phytate; (3) in the case of malted seeds, little toxicity is expected for consumers of the feed, because the malted seeds have long been used in the brewing and food industries and are known to be harmless to humans and animals; and (4) the cost of manufacturing feed for monogastric animals is reduced because an exogenous enzyme does not need to be added to the raw material.
In addition, the transgenic plants of the irwention, or organs and seeds thereof, can be used to produce hydrolytic enzymes for a variety of industrial processes. Examples of such applications are in feed additives for non-ruminants, in soy processing, in food processing, or in the production of inositol or inositol-phosphates from phytate.
Other features or advantages of the present invention will be apparent from the following detailed description, and also from the claims.
Brief Description of the Drawings Fig. 1 is a line graph of pH versus phytase activity.
Fig. 2 is a line graph of pH versus acid phosphatase activity.
Fig. 3 is a bar graph of various transgenic plants versus amount of APU
produced therein. The filled bars represent plant samples grown in sucrose.
The open bars represent plant samples grown without sucrose. "NT" is the non-transformed control.
Figs. 4 and 5 are bar graphs of various transgenic lines versus amount of APU. "NT" is the non-transformed control.
Fig. 6 is a bar graph of various transgenic lines versus specific activity for APU.
Figs. 7 and 8 are bar graphs of various transgenic lines versus sugar concentration. "NT" is the non-transformed control.
Detailed Description of the Invention The invention relates to transgenic plants that produce seeds useful as the 20 raw material for a phosphorus or carbohydrate-rich feed. The superior quality of the seeds and the resulting feed is due to the insertion of a transgene containing a promoter active in a plant seed tissue and that highly expresses an enzyme in a seed tissue of a transgenic plant. Of course, the enzyme may be expressed elsewhere in a transgenic seed or plant without affecting the advantages that the invention offers.
Seeds produced from such a plant can have reduced phytate and increased dietary phosphorus content, or reduced complex carbohydrates and increased simple carbohydrates, compared to a control plant that does not contain the transgene.
Phytate (myo-inositol hexakisphosphate) is the main storage form of phosphorus in many seeds. Phytin is the insoluble mixed potassium, magnesium, and calcium salt of myo-inositol hexaphosphoric acid (phytic acid). In cereals, oil seeds, and legumes, phytate accumulates in seeds during maturation and accounts for 50 to 80% of total phosphorus content of the seed. Soybean and corn meal are major components of animal feed. They contain adequate phosphorus levels to meet animal growth requirements, so long as phosphorus from the phytate is digestible 5 (i.e., absorbable) by the animal. Ruminants (multigastric animals) readily cleave phytate to release digestible phosphorus. However, monogastric animals (e.g., pigs, poultry, and fish) utilize phytate extremely poorly because they are deficient in gastrointestinal (GI) tract enzymes capable of hydrolyzing phytate. This deficiency necessitates supplementation of animal feed with phosphorus to meet dietary 10 requirements. Further, phytate chelates important cations (including iron, magnesium, manganese, zinc, calcium, copper, and molybdenum) and forms phytate-cation-protein complexes, thereby lowering the bioavailability of minerals and amino acids in the feed. Thus, the invention provides a means to release phosphorus by degrading phytate in raw materials used for animal feed.
15 Phytase produced in a transgenic plant or seed of the invention can also be used in a process for steeping corn or sorghum kernels. The plant tissue or seed can be ground before adding to steeping corn. Phytase liberated from the plant tissue or seed can act on phytin, which is present in many corn preparations. The transgenic cereal grains, if they are corn or sorghum grains, can produce phytase to degrade 20 phytin in situ. Degradation of phytin in corn steeping increases the nutrient content and consequently the commercial value of corn steep liquor, which is used as animal feed or as a nutrient in microbial fermentation. Furthermore, the degradation of phytin can prevent problems relating to the accumulation of phytin deposits in filters, pipes, reactor vessels, etc. during concentration, transport and storage of corn 25 steep liquor. The action of phytase can also accelerate the steeping and separation processes involved in corn wet milling. _ In addition, the use of transgenic seeds containing starch-hydrolyzing enzymes (e.g., amylopullulanase) is compatible and desirable with currently used processes in food and wine industries for production of sugars using cereal grain 30 starch. Rice provides the main source of food for more than 50% of the world population and is the most important and widely grown crop on earth. Due to the large biomass, rice seeds are an ideal sources of soluble sugars for the food and wine industries. Amylopullulanase (APU) from Thermoanaerobacter ethanolicus 39E, harboring both pullulanase and a-amylase activities, is capable of hydrolyzing both 5 a-1,4 and a-1,6 bonds of polysaccharides and is heat stable with a catalytic optimum of 90°C. Generally, rice contains 6-10% protein and 70-80%
starch by weight. APU can hydrolyze the starch to produce soluble sugars and at the same time increase the relative composition of insoluble rice flour. High protein rice flour has high nutritional value and is useful for the production of pudding, gruel, instant 10 milk, baby food, etc. As shown below, a 2.9-kb DNA fragment of the APU gene that encodes amino acids 75 to 1029 of the mature APU (total of 1481 amino acids) of T. ethanolica~s was isolated and characterized. This truncated APU
maintains both a-amylase and pullulanase activities. The use of transgenic rice seeds containing the dual active APU in the production of sugars from seed starch 15 simplifies the production process and significantly reduces production cost for rice flour.
The genetic elements necessary for constructing the transgene to be inserted into the plant is readily available. For example, a-amylase promoters are described in U.S. Patent No. 5,460,952 and in the Example below. Other suitable promoters 20 are described in McElroy et al., Plant Mol. Biol. 15:257-268, 1990;
Brusslan et al., Proc. Natl. Acad. Sci. USA 89:7791-7795, 1992; Wissenbach et al., Plant J.
4:411-422, 1993; Reynolds et al., Plant Mol. Biol. 29:885-896, 1995; Kaukinen et al., Plant Mol. Biol. 30:1115-1128, 1996; Beaudoin et al., Plant Mol. Biol. 33:835-846, 1997;
Moore et al., Proc. Natl. Acad. Sci. USA 94:762-767, 1997; Odell et al., Nature 25 313:810-812, 1985; and U.S. Patent Application entitled "Plant Seedling and Embryo Promoter," filed May 22, 2000, naming-inventors Su-May Yu and Yu-Chan Chao. Other genetic elements, such as cis-regulatory sequences are also available to the skilled artisan. See, e.g., U.S. Patent No. 5,969,127.
The expression constructs containing the transgene can be inserted into a 30 vector, such as a plasmid, which is then introduced into plants using Agrobacterium tumefaciens-mediated DNA delivery or particle bombardment, which are standard methods known in the art.
The DNA sequence encoding an enzyme may be obtained from a variety of sources such as microbial, plant, or animal sources. For example, a DNA
sequence encoding a phytase can be cloned from a ruminal bacterium by, e.g., screening of bacterial cDNA libraries or PCR amplification of nucleic acids using heterologous or degenerate probes.
The cloned genes described herein may be used as starting materials for the construction of "second generation" enzymes whose amino acid sequence has been altered by mutagenesis (e.g., site-directed mutagenesis), which have beneficial properties that differ from those of wild-type or recombinant enzymes. For example, the temperature or pH optimum, specific activity, or substrate affinity can be altered so as to be better suited for application in a defined process.
Several techniques are available for the introduction of the expression 15 construct containing the enzyme-encoding DNA sequence into plants or cells from which transgenic plants can be produced. Such techniques include electroporation, microinjection, the ultrasonic method, polyethylene glycol-mediated protoplast transformation, the poly-L ornithine method, the calcium phosphate method, and particle bombardment.
In addition to these so-called direct DNA transformation methods, transformation systems involving vectors are widely available, such as viral vectors (e.g., from the cauliflower mosaic virus, CaMV) and bacterial vectors (e.g., from the genus Agrobacterium). After selection and/or screening, the protoplasts, cells, or plant parts (e.g., explants) that have been transformed can be regenerated into whole plants, using methods known in the art.
For transformation and regeneration of cereal crops, an embodiment of the present invention uses the principle of the binary vector system (Hoekema et al., Nature 303:179-180. 1983; and European Patent Application No. 0120516) in which Agrobacterium strains containing a vir plasmid with the virulence genes and a 5 compatible plasmid with the gene construct to be transferred. The binary vectors as used in this example contain, between the left- and right-border sequences of the T-DNA, an hph gene coding for hygromycin resistance and a multiple cloning site for insertion of gene constructs.
The promoter used for directing the expression of the phytase can be an 10 a-amylase gene promoter. The a-amylase gene promoters are active in germinating seeds (Huttly et al., EMBO J. 8:1907-1913, 1989; Skriver et al., Proc. Natl.
Acad.
Sci. USA 88:7266-7270, 1991; Lanahan et al. Plant Cell 4:203-21 l, 1992;
Tanida et al., Mol. Gen. Genet. 244:127-134, 1994; Itoh et al., Plant Physiol. 107:25-31, 1995), sucrose-starved suspension cells (Chan et al., J. Biol. Chem. 269:17635-15 17641, 1994), and other tissues and organs (Chan et al., Plant Mol. Biol.
22:491-506, 1993) of cereal crops.
The transgene can further includes a signal peptide sequence derived from the a-amylase genes or another gene that is capable of directing the recombinant proteins toward the endoplasmic reticulum, vacuole, protein body, or extracellular 20 space. Other regulatory sequences, such as terminator sequences and polyadenylation signals that function in plants, can be included in the transgene. An example of one such sequence is the 3' untranslated region of the nopaline synthase (Nos) gene ofAgrobacterium tumefaciens or the 3' untranslated region of a rice a-amylase gene (U.S. Patent No. 5,969,127).
25 Once a transgenic plant of the invention is produced, expression in tissues other than a seed tissue can be beneficial. For example; the transgenic plant can be used as a producer of a recombinant phytase, whether the phytase is isolated from a leaf, sheath, stem, or root of the transgenic plant.
Phytase activity can be measured using any method known in the art, 30 including ELISA, Western blotting, and direct enzyme assays using colorimetric techniques or native gel assays. See e.g., Shimizu, Biosci. Biotech. Biochem.
56:1266-1269, 1992; Yanke et al., Microbiology 144:1565-1573, 1998; and Kim et al., Enzyme Microb. Technol. 22:2-7, 1998.
The transgenic plants, plant organs, or malted seeds can be used directly, i.e., without further processing, or can first be processed via conventional means such as grinding to a consistency suitable for a particular use. Alternatively, the phytase can be extracted from the plant, plant organ, or malted seeds and, if desired, purified before use using conventional extraction methods and purification techniques.
See, e.g.; Laboure et al., Biochem. J. 295:413-419, 1993; and Golovan et al., Can.
J.
Microbiol. 46:59-71, 2000.
Without further elaboration, it is believed that one skilled in the art can, based on the above disclosure, and the production of transgenic plants and seeds as described below, utilize the present invention to its fullest extent. The following examples are to be construed as merely illustrative of how one skilled in the art can isolate and use the transgenic plants of the invention, and are not limitative of the remainder of the disclosure in any way. Any publications, patents, or patent applications cited in this disclosure are hereby incorporated by reference.
ny a r~rnr ~ ~
The methods, materials, and procedures used in the present example are first described.
Methods and Materials Plant Material. The rice variety used in this example was Oryza sativa L.
cv. Tainung 67. Immature seeds were dehulled, sterilized with 2.4% NaOCI for 1 hour, washed extensively with sterile water, and placed on N6D agar medium for callus induction as described in Toki, Plant Mol. biol. Rep. 15:16-21, 1997.
After one month, calli derived from scutellae were subcultured in fresh N6D medium for transformation or in a liquid MS medium containing 3% sucrose and 10 pM 2,4-D
to establish a suspension cell culture as previously described in Yu et al., J. Biol.
Chem. 266:21131-21137, 1991.
Plasmids. Plasmid aAmyB-C carries a 1.4-kb rice a-amylase cDNA insert in pBluescript KS+ (Stratagene) (Yu et al., Gene 122:247-253, 1992). Plasmid pRYl8 carries a 3.8 kb DNA fragment that contains a rice genomic rDNA cluster, including the 3' halfportion of 18S rRNA gene, the complete 5.85 rRNA gene, and 5 the 5' half portion of the 25S rRNA gene in pUCl3 (Sano et al., Genome 33:209-218, 1990). Plasmid RAMYG6a contains the 3' half portion and 3' flanking region of aAmy8 genomic DNA and was generated from screening a rice genomic DNA
library (Clontech) using aAmyB-C as a probe. The selected clone was subsequently subcloned from a positive EMBL-3 phage clone into pBluescript (Stratagene).
10 Plasmid RAMYG 17 contains the 5' flanking region, the entire coding region, and the 3' flanking region of aAmy7 genomic DNA and was generated from screening a rice genomic DNA library (Clontech) using aAmyB-C as a probe. Further details regarding RAMYG6a and RAMYG17 can be found in Ho et al., Master's Thesis, Department of Biology, National Taiwan Normal University, 1991. The selected 15 clone was subsequently subcloned from a positive EMBL-3 phage clone into pBluescript.
Plasmid Construction. The 5' end of the S. ruminantium phytase gene (SrPf~ was modified by PCR using the plasmid pSrPf6 (U.S. Patent No.
5,939,303) as a DNA template and the primers 5'-TTAAGCGATATCGCCAA
20 GGCCCCGGAACAGA-3' (SEQ ID NO:1; EcoRV site underlined) and 5'-ACGCAGGATCCACCTCATAAAACC-3' (SEQ ID N0:2; BamHI site underlined) to yield a recombinant gene in which an EcoRV site was incorporated immediately 5' to the codon (bolded in SEQ ID NO:1 ) specifying the first amino acid of the mature, processed phytase enzyme and a BamHI site at the end of the 25 phytase gene. The EcoRV site allows for the fusion of the phytase gene to the signal peptide sequence of the a-amylase gene aAmyB.~ The PCR product was subcloned into the EcoRV and BamHI sites of pBluescript (Stratagene) to generated pBS/SrPf6.
The E. coli phosphatase gene appA was similarly modified by PCR at the 5' 30 and 3' ends using plasmid pET-appA (Golovan et al., Can. J. Microbiol.
46:59-71, 2000) as a DNA template and the oligonucleotides 5'-ACGGCGGATATCCAGAGTGAGCCGG AGCTGA-3' (SEQ ID N0:3; EcoRV site underlined) and S'-AGGTTGGATCCTTACA AACTGCACGAAGG GT-3' (SEQ
ID N0:4; BamHI site underlined). The resulting PCR product was subcloned into pBluescript to generate pBS/appA.
A 1.2 kb promoter and signal peptide region of aAmy8 was excised with SaII
and Hi~zdIII from pAG8 (Chan et al., Plant Mol. Biol. 22:491-506, 1993) and subcloned into pBluescript to generated pBS/BSP. The aAnzy8 3'untranslated region (3'UTR) was PCR-amplified using RAi~IYG6a as the DNA template and the 10 oligonucleotides 5'-CG GGATCCTAGCTTTAGCTATAGCGAT-3' (SEQ ID NO:S;
BamHI site underlined) and 5'-TCCCCGCGGGTCCTCTAAGTGAACCGT-3' (SEQ ID N0:6; SacII underlined). The nopaline synthase gene (Nos) 3'UTRs was PCR-amplified using pBI221 (Clontech) as the DNA template and the oligonucleotides 5'-TCCGGATCCCAGATCGTTCAAAC ATTT-3' (SEQ ID N0:7;
15 BamHI site underlined) and 5'-AGCCCGCGGGATCGATCTA GTAACAT-3' (SEQ
ID N0:8; SacII underlined).
The aAmy8 and Nos 3'UTRs were subcloned into the BamHI and SacII sites in pBS/8SP to generate pBS/8SP8U and pBS/8SPNos, respectively. The SrPf6 was excised with EcoRV and BamHI from pBS/SrPf6 and subcloned into the same sites 20 in pBS/8SP8U and pBS/8SPNos to generate pBS/8F8U and pBS/BFN, respectively.
The appA gene was excised with EcoRV and BamHI from pBS/appA and subcloned into the same sites in pBS/8SP8U and pBS/BSPNos to generate pBS/8A8U, and pBS/BAN. The correct in-frame fusion of the aAnry8 signal peptide sequence with the SrPf6 or appA coding region, and the junction regions which link the SrPf6 or 25 appA coding region with the aAmy8 3'UTR or Nos 3'UTR were all verified by DNA sequencing.
The 1.7-kb promoter and signal peptide region of aAmy7 was PCR-amplified using RAMYGI7a as a DNA template and the oligonucleotides 5'-ACCGGGTCGAC GTATACATGTCACCTACA-3' (SEQ ID N0:9; SaII site 30 underlined) and 5'-GGTGATATCCAGGACTT GCCCGGCTGT-3' (SEQ ID
NO:10; EcoRV site underlined) to yield a PCR product having a SaII site at the 5' end of the aAnZy7 promoter and an EcoRV site immediately 3' to the signal peptide sequence. The PCR product was subcloned into the SaII and EcoRV sites in pBluescript to generate pBS/7SP. The aAmy7 3'UTR was PCR-amplified using RAMYG17 as the DNA template and the oligonucleotides 5'-GCTCTAGAAATCTGAGCGCACGATG-3' (SEQ ID NO:11; XbaI site underlined) 5'-TCCCCGCGGTAAGCATTAAGCAGTGCA-3'(SEQ ID N0:12; SacII site underlined. The PCR product was subcloned into the XbaI and SacII sites in pBS/7SP to generate pBS/7SP7U. The Nos 3'UTR was excised withXbaI and SacII
10 from pBS/BSPN and subcloned into the same sites in pBS/7SP to generate pBS/7SPNos. The SrPfG gene was excised with EcoRV and BamHI from pBS/SrPf6 and subcloned into the same sites in pBS/7SP7U and pBS/7SPNos to generate pBS/7F7U and , pBS/7FN, respectively. The appA gene was excised with EcoRV
and BamHI from pBS/appA and subcloned into the same sites in pBS/7SP7U and 15 pBS/7SPNos to generate pBS/7A7U and pBS/7AN, respectively. The correct in-frame fusion of the aAmy7 signal peptide sequence with the SrPf6 or appA
coding region, and the junction regions which link the SrPf6 or appA coding region with the aAmy7 3'UTR or Nos 3'UTR are all verified by DNA sequencing.
The cauliflower mosaic virus 35S RNA (CaMV35S) promoter-hygromycin 20 B phosphotransferase (hph) coding sequence-tumor morphology large gene 3'UTR
(tml) fusion gene was excised with EcoRI from pTRA 1 S 1 (Zheng et al., Plant Physiol. 97:832-835, 1991) and subcloned into the EcoRI site of the binary vector pPZP200 (Hajdukiewicz et al., Plant Mol. Biol. 25:989-994, 1994) to generate pPZP/HPH. pPZP/HPH was linearized with SaII and blunted-ended to served as a 25 vector for cloning. pBS/8F8U, pBS/BFN, pBS/8A8U, pBS/8AN, pBS/7F7U, pBS/7FN, pBS/7A7U, and pBS/7AN were lineanzed with PvuII to serve as inserts for cloning. The inserts were ligated with the vector to generate pPZP/8F8U, pPZP/8FN, pPZP/8A8U, pPZP/BAN, pPZP/7F7U, pPZP/7FN, pPZP/7A7U, and pPZP/7AN, respectively.
Rice Transformation. Plasmids were introduced into Agrobacteriz~m tumefaciens strain EHA101 (Hood et al., J. Bacteriol. 168:1291-1301, 1986) with an electroporator (BTX) following the manufacturer's instruction. Calli induced from immature rice seeds were co-cultured with Agrobacterium according to the methods described by Hiei et al., Plant J. 6:271-282, 1994 and Toki et al., supra.
Northern Blot Analysis. Total RNA was isolated from endosperms of germinating seeds as described in Yu et al., Plant Mol. Biol. 30:1277-1289, 1996 and isolated from cultured suspension cells using a TRIZOL reagent (GIBCO BRL).
RNA gel blot analysis was performed as described in Thomas, Methods Enzymol.
100:255-266, 1983. Briefly, 10 ~g of total RNA was electrophoresed on a 1%
agarose gel containing 10 mM sodium phosphate buffer (pH 6.5), transferred to a nylon filter, and hybridized with 32P random primer labeled SrPf6 DNA, appA
DNA, czAmyB gene-specific DNA, or rDNA probe. The aAmy8 gene-specific DNA was prepared as described in Sheu et al., J. Biol: Chem. 271:26998-27004, 1996.
The blot was visualized using autoradiography and quantified using software accompanying the of a PhosphoImager (Molecular Dynamics).
Western Blot Analysis. Total proteins were extracted from endosperms of germinating seeds using an extraction buffer (SO mM Tris-HCl [pH 8.8], 1 mM
EDTA, 10% glycerol, 1% Triton X-100, 10 mM (3-mercaptoethanol, and 0.1%
sarkosyl). Western blot analysis was performed as described by Yu et al., J.
Biol.
Chem. 266:21131-21137, 1991.
Phytase Activity Assay. Protein extract was prepared from the germinating seeds as described by Li et al., Plant Physiol. 114:1103-1111, 1997. The phytase activity was determined as described in Shimizu, Biosci. Biotech. Biochem.
56:1266-1269, 1992.
Results The aAmy8 promoter confers sucrose starvation-enhanced accumulation of appA and SrPf6 mRNAs in transformed rice suspension cells. To determine whether the crAmy8 promoter controls sugar-dependent expression of appA in rice, a 1.2-kb DNA fragment containing the 5' regulatory and signal peptide sequences of aAmyB
was fused in-frame at the S' end of the appA or SrPf6 gene. The chimeric gene was inserted into a binary vector and introduced into Agrobacterium for rice transformation. Many transformed cell lines were obtained and eight lines were selected for further study. The transformed calli were cultured as suspension cells, and the suspension cells were then cultured in medium with or without sucrose.
Total RNA was purified and subjected to gel blot analysis using appA DNA, SrPf6 DNA, crAmy8 gene-specific DNA, or rDNA as a probe. Accumulation of appA, SrPf6, and aAmy8 mRNAs were detectable in cells starved of sucrose but not in cells provided with sucrose. No appA or SrPf6 mRNA was detected in the non-transformed (NT) cells.
The aAmy8 promoter confers sucrose starvation-enhanced activity of phytase in transformed rice suspension cells. To determine whether the transformed rice suspension cells carrying an aAmyB-appA or aAmyB-SrPf6 chimeric gene synthesize and secrete phytase into the culture medium, the phytase activity in 15 suspension cells and in culture medium were determined. The phytase activity was detectable in the transformed cells and in the culture medium. In both cases, phytase activity was significantly enhanced by sucrose starvation. The phytase activity was also detectable in the non-transformed cells under sucrose starvation, which was probably caused by the endogenous phytase gene.
The aAmy7 and aAmy8 promoters control expression of SrPf6 in germinating transgenic rice seed. Transgenic rice plants were regenerated from the transformed rice calli carrying aAmy7-SrPf6 or crAmyB-SrPf6. The T1 seeds of some transgenic lines were randomly selected for further study. To determine the role of the aAmy7 and aAmyB promoters in the expression of appA and SrPf6 genes during seed germination, the transgenic rice seeds were germinated for 5 days.
Total RNA was purified from the entire germinated seed (including the shoots, roots, and endosperms) and subjected to gel-blot analysis using SrPf6 DNA, crAmyB gene-specific DNA, or rDNA as a probe. Under the control of czAmy7 promoter, expression of SrPf6 could be detected in some of the germinated seeds. Under the control of aAmyB promoter, expression of SrPf6 could be detected in all the germinated seeds. No SrPfG mRNA was detected in non-transformants.
The aAmy8 promoters control expression of appA ira germinating transgenic rice seed. Transgenic rice plants were regenerated from the rice calli carrying 5 aAmyB-appA. The T1 seeds of some transgenic lines were randomly selected for further study. Seeds were germinated for 5 days and total RNA was purified from the entire germinated seeds (including the shoots, roots, and endosperms) and subjected to gel-blot analysis using appA DNA, aAmy8 gene-specific DNA, or rDNA as a probe. Under the control of the aAmy8 promoter, expression of appA
could be detected in all germinated seeds. No appA mRNA was detected in the non-transformants.
The aAnZy8 promoter confers high phytase activity in germinating transgenic rice seeds. To determine the expression level of phytase in germinated transgenic seeds, phytase activity in the T1 transgenic seeds were analyzed. The transgenic rice 15 seeds were germinated for 5 days. Cell extract was prepared from the entire germinated seeds (including the shoots, roots, and endosperms) and subjected to phytase activity analysis. Phytase activity was higher in all the germinated transgenic seeds carrying the aAmyB-SrPf6-Nos chimeric gene than in the non-transformants. One of the transgenic lines, 8FN-8, had significantly higher phytase activity as compared with other transgenic lines. Phytase activity was higher in all the germinated transgenic seeds carrying the aAmyB-appA chimeric gene than in the non-transformant. One transgenic line, 8AN-14 had significantly higher phytase activity as compared with other transgenic lines including 8FN-8.
The introduced phytase and acid phosphatase genes are inherited to the progenies of transgenic rice. To determine whether the introduced appA and SrPf6 DNAs were inherited to the progenies of Tl transgenic rice, the T2 seeds of transgenic lines 8AN-14 and 8FN-8 were germinated for 5 days. Total RNA was purified from the entire germinated seeds and subjected to gel blot analysis using appA DNA, SrPf6 DNA, or rDNA as a probe. Expression of appA and SrPf6 was 30 detected in most of the germinated T2 seeds.
The aAmy8 promoter confers temporal expression of phytase in germinating transgenic rice seed. To determine the expression pattern of phytase in germinated transgenic rice seed carrying aAmyB-appA or aAmyB-SrPf6, the T2 seeds of transgenic lines 8FN-8-8 and 8AN-14-10 were germinated for various lengths of time, and phytase activity was determined. The phytase activity in the transgenic seeds increased as germination proceeded and reached a peak at days 5-6 while declining afterwards. Phytase activity was also detectable in the non-transformed seeds, but remained at low level throughout the entire germination period.
The molecular weight of phytase produced in germinating transgenic rice seeds is similar to that produced in Pichia pastoris. SrPf6 was cloned into a plasmid under the control of the glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter and overexpressed in Pichia pastoris. The SrPf6 cDNA was PCR-amplified using pSrPf6 as the DNA template and oligonucleotides 5' -CGGAATTCGCCAAGGCGCCGGAGC AGAC-3' (SEQ ID N0:25) (EcoRI site underlined) as S' primer and 5' -GCTCTAGATACGCCTTC GCCGGATGGCT-3' (SEQ )D N0:26) (Xbal site underlined) as 3' primer. The DNA fragment containing SrPf6 cDNA was digested with EcoRI and Xbal and ligated into the same sites in pGAPZaA (Invitrogen) to generate pGAP-SrPf6. SrPf6 was led by a signal peptide a-factor and was under the control of GAP promoter. pGAP-SrPf6 was linearized by restriction enzyme AvrII and transferred into P. pastoris host strain SMD
1168H by electroporation. The transformed cells were plated on YPDS (1% yeast extract, 2%
peptone, 2% dextrose, 1 M sorbitol, pH 7.5) plus zeocin (100 mg/ml) at 30°C for 3 days. Production and purification of phytase were performed according to the manufacturer's instruction provided with pGAPZaA.
To compare the molecular weight of phytase produced in germinating transgenic rice seeds with that of the phytase overexpressed in Pichia, seeds of transgenic rice line 8FN-8 were germinated for 5 days. Total proteins were extracted from the entire germinated seeds and subjected to Western blot analysis using phytase polyclonal antibodies. The full-length cDNA of SrPf6 was PCR-amplified using plasmid pSrPf6 as DNA template and oligonucleotides 5'-CCCGAATTCATGAAATACTGGCAG-3' (SEQ ID N0:27) (EcoRI site underlined) as 5' -primer and 5' -CCCGAGCTCTTACGCCTTCGCCGG-3' (SEQ ID N0:28) (SacI site underlined) as 3' primer. The amplified DNA fragment was digested with EcoRI and SacI and ligated into the same sites in pET20b(+) (Novagen) to generate pET-SrPf6. pET-SrPf6 was transferred to E. coli strain BL21 (DE3) and expressed.
Purification of phytase was performed according to the instruction provided by Novagen. One hundred micrograms of purified phytase was injected into a New Zealand White rabbit successively at 4-6 week interval according to the methods generally described in Williams et al., "Expression of foreign proteins in E.
coli using plasmid vectors and purification of specific polyclonal antibodies," In: DNA
Cloning 2. Expression Systems: A Practical Approach, Glover et al., eds., IRL Press, New York, 1995.
The molecular weight of the full-length phytase produced by germinating transgenic seeds was similar to that produced by Pichia. It was known that the phytase encoded by SrPf6 had a molecular weight of 36.5 kD when expressed in E.
coli (U.S. Patent No. 5,939,303). The molecular weight of phytase expressed in Pichia was about 36.5 kD and 38 kD. Similarly, when the phytase was expressed in transgenic rice seeds the molecular weight was about 36.5 kD and 40 kD. It was known that there is one potential glycosylation site in the primary structure of SrPf6 (U.S. Patent No. 5,939,303). The 38 kD and 40 kD phytases expressed in Pichia and transgenic rice seeds, respectively, were probably caused by differential glycosylation. One protein with molecular weight of 34 kD was also present in the germinating rice seeds, which could have been a degradation product of the phytase.
These results indicate that the mature phytase produced in the transgenic plants and seeds described herein were properly post-translationally modified.
Transgenic germinated rice seedlseedling contained phytase with high specific activity and broad pHprofiles for high activity. Unexpectedly, it was also discovered that the phytase specific activity expressed in the germinated transgenic seeds is two fold higher than that expressed in E. coli. The reason for this surprising result could be that there are many endogenous hydrolytic enzymes simultaneously expressed in the germinated seeds. These hydrolytic enzymes may have a synergistic effect on the phytase activity present in germinating seeds.
Alternatively, or in conjunction, the post-translationally modified phytase in the germinating seeds may have increased the enzyme's specific activity, which resulted in the observed increase in phytase activity. Thus, besides the advantages of expressing phytase in transgenic malted seeds, the specific activity of the recombinantly produced enzyme was also increased.
The ruminal bacterial phytase has a pH optimum of 4.0-5.5 (U.S. Patent No. 5,939,303). To determine the optimal pH of phytase expressed in the rice seeds described above, T2 seeds of three transgenic rice lines were germinated for 5 days, 10 and the optimal pH for phytase expressed in rice germinated seed/seedling was determined. The results showed that the activity of phytase expressed in all three transgenic rice lines was optimal at pH 3 and pH 4.5-5.0 (Fig. 1). In the digestive tract of monogastric animals, the pH ranges from 2-3 in the stomach and 4-7 in the small intestine. The broader and more acidic optimal pH profile of phytase expressed in rice allows the enzyme to function well in the stomach and small intestine of animals and is therefore an advantage for its use as a feed additive. The reason for this surprising result could be that the phytase expressed in rice was post-translationally modified, which resulted in the increase in activity and/or stability over a broad range of pH.
20 The E. coli acid phosphatase has a pH optimum of 2.5 (Dassa et al., J.
Biol.
Chem. 257:6669-6676, 1982; and Dassa et al., J. Bacteriol. 172:5497-5500, 1990).
To determine the optimal pH of acid phosphatase expressed in rice, T2 seeds of transgenic rice line 8AN-14-6 were germinated for 5 days, and the optimal pH
for phytase expressed in germinated rice seed/seedling was determined. The results 25 show that activity of acid phosphatase expressed in rice was optimal over a pH range of 3-5.5 (Fig, 2) . As with the ruminal bacterial phytase expressed in rice, the broader and more acid optimal pH profile of E. coli acid phosphatase would allow the enzyme to function well in the stomach and small intestine of animals and is therefore an advantage for its use as a feed additive. The reason for this surprising 30 result also could be that the acid phosphatase expressed in rice was post-translationally modified, which resulted in increase in activity and/or stability over a broad range of pH.
~~r a r~rpr ~ ~
The methods, materials, and procedures used in the present example are first described.
Materials and Methods Plant Material. All pant materials were prepared as described in Example 1.
Preparation of genomic DNA. Rice seeds were germinated and grown in the dark for 1 week. Bacteria T. ethanolicus 39E was obtained from the American Type Culture Collection (ATCC 53033). The bacterial and rice genomic DNA was purified according to the method described in Sheu et al., J. Biol. Chem 271:26998-27004, 1996.
PCR. The 1351-by glutelin gene promoter region (Fragment I; Zheng et al., Plant J. 4:357-366, 1993; and Wu et al., Plant Cell Physiol. 39:885-889, 1998) was PCR-amplified using rice genomic DNA as template and primers B1-5 (5'-GGGGAATTCGA TCTCGATTTTTGAGGAAT-3' [SEQ ID N0:13], EcoRI site underlined) and B 1-3 (5'-GGGGGATCCCATAGCTATTTGTACTTGCT-3' [SEQ ID
N0:14], BamHI site underlined). The glutelin gene promoter plus 75-by putative signal peptide sequence (Fragment II) was PCR-amplified using rice genomic DNA
as template and primers B1-5 and B1-sp (5'GGGGGATCCGGGATTAAATAGCTGGGCCA-3' [SEQ ID N0:15], BamHI
site underlined). The glutelin gene promoter plus putative signal peptide and propeptide sequences (Fragment III) was PCR-amplified using rice genomic DNA
as template and primers B1-5 and B1-pro (5'GGGGGATCCCCTCACTTTCCGAAG TGGTT-3' [SEQ ID N0:16], BamHI
site underlined).
The truncated apu ORF encoding only amino acid 75 to 1029 was PCR-amplified using the genomic DNA of T. ethanolicus 39E as template and oligonucleotides 5'-CGG GATCCTTAAGCTTGCATCTTGA-3' (SEQ ID N0:17;
BamHI site underlined) as forward primer and 5'-CCGGCGGCCGCCTACATATTTTCCCCTTGGCCA-3' (SEQ ID N0:18; NotI site underlined) as reverse primer.
Plasmid construction. The PCR-amplified Fragments I, II, and III were 5 digested with EcoRI and BamHI and subcloned into the same sites in pBluescript (Stratagene) to generate pBS-G, pBS-Gp, and pBS-Gpp, respectively. The truncated apu was digested with BamHI and NotI and fused downstream of the GIuB-1 promoter, GIuB-1 promoter-signal peptide sequence, and GIuB-1 promoter-signal peptide-propeptide sequence in pBS-G, pBS-Gp, and pBS-Gpp, respectively, to 10 make translational fusions and to generate plasmids pBS-G-apu, pBS-Gp-apu, and pBS-Gpp-apu, respectively. The nopaline synthase gene (Nos) 3' untranslated (UTR) was PCR-amplified using pBI221 (Clontech) as DNA template and oligonucleotide 5'-TCCGAGCTCCAGATCGTTC AAACATTT-3' (SEQ ID
N0:19; SacI site underlined) as forward primer and oligonucleotide 5'-15 AGCGAGCTCGATCGATCTAGTAACAT-3' (SEQ ID N0:20; SacI underlined) site as reverse primer. The Nos 3'UTR was digested with SacI and fused downstream of apai in pBS-G-apu, pBS-Gp-apu, and pBS-Gpp-apu to generate pBS-G-apu-Nos, pBS-Gp-apu-Nos, and pBS-Gpp-apu-Nos, respectively.
The 1.2 kb promoter and signal peptide sequence of crAmy8 was excised with 20 SalI and HindIII from pAG8 (Chan et al., Plant Mol. Biol. 22:491-506, 1993) and subcloned into pBluescript to generate pBS/8sp. The aAmy8 3'UTRs was PCR-amplified using RAMYG6a as a DNA template and oligonucleotide 5'-CGCCGCGGTAGCTTTA GCTATAGCGAT-3' (SEQ ID N0:21; SacII site underlined) as forward primer and oligonucleotide 5'-25 TCCCCGCGGGTCCTCTAAGTGAACCGT-3' (SEQ ID N0:22; SacII site underlined) as reverse primer. Plasmid RAMYG6a contains the 3' half portion of the coding sequence and 3' flanking region of aAmy8 genomic DNA and was generated by screening of a rice genomic DNA library (Clontech) using crAmyB-C
(Yu et al., Gene 122:247-253, 1992) as a probe. The aAmyB 3'UTRs was subcloned 30 into the SacII sites in pBS/8sp to generate pBS/8sp8U. The truncated apu was cut with BamHI and NotI and subcloned into the same sites in pBS-8sp8U to generate pBS-aAmyB-sp-apu-8U.
The 1.1-kb promoter and signal peptide sequence of aAmy3 was excised with SaII and HindIII from p3G-132II (Lu et al., J. Biol. Chem. 273:10120-10131, 1998) and subcloned into pBluescript to generate pBS-asp. The aAmy3 3'UTR was excised with HindIII and SacI from pMTC37 (Chan et al., Plant J. 15:685-696, 1998) and subcloned into the same sites in pBS-asp to generate pBS-3sp3U. The truncated apu was digested with BamHI and NotI and subcloned into the same sites in pBS-3sp3U to generate pBS-aAmy3-sp-apu-3U.
10 The correct in-frame fusion of the GIuB, aAnry3, and aAmy8 signal peptide or propeptide sequence with the apu coding region, the junction regions which link the apu coding region with the aAmy3, aAnzyB, or Nos 3'UTR were all verified by DNA sequencing. The GIuB-apu-Nos, GIuB-sp-apu-Nos, GIuB-spp-apu-Nos, aAmy3-sp-apu-aAmy3 3'UTR, and aAmyB-sp-apu-aAmy8 3'UTR chimeric genes were excised from pBS-G-apu-Nos, pBS-Gp-apu-Nos, pBS-Gpp-apu-Nos, pBS-aAmy3-sp-apu-3U, and pBS-aAmyB-sp-apu-8U with SaII, blunt-ended, and inserted into the HindIII-digested and blunt-ended binary vector pSMYIH (Ho et al., Plant Physiol. 122:57-66, 2000) to generate pSMYI/Gapu, pSMYl/Gpapu, pSMYI/Gppapu, and pSMYI/3apu and pSMYI/8apu, respectively.
Transformation. Transformations were carried out as described in Example 1.
Expression of APU in E. coli and preparation of antibodies. The truncated apu encoding amino acids 75 to 1029 was PCR-amplified using genomic DNA of T.
ethanolicz~s 39E as template and oligonucleotides 5'-CGCATATGTTAAGCTTGC
25 ATCTTGATTC-3' (SEQ ID N0:23; NdeI site underlined) as forward primer and 5'-CCGCTCGAGCTACATATTTTCCCCTTGGCCA-3' (SEQ ID N0:24; XhoI site underlined) as reverse primer. The amplified DNA fragment was digested with NdeI
and XhoI and ligated into the same sites in pET20b(+) (Novagen) to generate pET-APU. pET-APU was transferred to E. coli strain BL21 (DE3), and APU was 30 expressed. Purification of APU was performed according to the instruction provided by Novagen. One hundred micrograms of purified APU was injected into a New Zealand White rabbit successively at 4-6 week interval according to the methods described in Williams et al., supra.
APU activity assay and enzyme-linked imnzzmosorbent assay (ELISA). Rice seeds or tissues were ground in liquid N2, lysed with a buffer (90.8 mM
KZHP04, 9.2 mM KH~P04, 10 mM EDTA, 10% glycerol, 1% Triton X-100, and 7 mM (3-mercaptoethanol) and centrifuged at 15,000 X g for 10 minutes. The supernatant was then collected. APU activity was assayed as described in Mathupala et al., J.
Biol. Chem. 268:16332-16344, 1993. ELISA was perfornled as described in Ausubel et al., Short Protocols in Molecular Biology, 2nd ed., In: A
Compendium of Methods from Current Protocols in Molecular Biology, John Wiley & Sons, New York, 1992. The total protein concentration was determined using a Bio-Rad protein assay kit based on the dye binding assay of Bradford (Bradford, Anal. Biochem.
72:248-254, 1976).
Determination of sugar concentration. Mature rice seeds were ground to powder with a mortar and pestle. Rice seedlings were ground to powder in liquid NZ
with mortar and pestle. Water was added to the powder to make a 10% (w/v) slurry.
The slurry derived from mature rice seeds was heated at 90°C for 30 minutes, total soluble sugars were extracted, and the concentration of sugars was determined as described in Chen et al., Plant J. 6:625-636, 1994. The slurry derived from rice seedlings was heated at 85°C for 2 hours, total soluble sugars were extracted, and the concentrations of glucose, fructose, sucrose, maltose, and maltotriose were determined by high-performance liquid chromatography (HPLC) as described in Shaw et al., Biosci. Biotech. Biochem. 56:1071-1073, 1992.
Results Isolation of the rice glutelin gene promoter, signal peptide, and propeptide sequences. Primers based on the nucleotide sequence of a glutelin gene (GIuB-1 ) (Takaiwa et al., Plant Mol. Biol. 17:875-885, 1991) were designed, and three DNA
fragments containing the GIuB-I promoter, putative signal peptide sequence, and putative propeptide sequence were synthesized using PCR. The putative 25-amino acid signal peptide cleavage site was predicted based on a statistical method (von Heijne, J. Mol. Biol. 184:99-105, 1985). The putative 36-amino acid propeptide cleavage site was predicted based on the sweet potato sporamin propeptide sequence (Matsuoka et al., Proc. Natl. Acad. Sci. USA 88:834-838, 1991). Fragment I
contained the 1351 by GluB-I promoter region ending right at the translation initiation codon. Fragment II contained Fragment I plus a 75 by signal peptide sequence. Fragment III contained Fragment II plus a 108 by putative propeptide sequence. The purpose for including the signal peptide or propeptide region was to target APU to different cellular compartments (e.g., cytoplasm, protein body, or vacuole). Effect of cellular localization on yield, stability, and activity of APU in transgenic rice seeds could then be compared. Transformed rice suspension cells expressed and secreted APU into the culture medium.
Transformed rice suspension cells expressed and secreted APU into the culture medium. All plasmids were delivered into rice calli by particle 15 bombardment or Agrobacterium-mediated transformation systems. The transfected rice calli were grown under hygromycin selection. Genomic Southern blot analyses of the transformed cell lines revealed that, in general, the transgenic lines obtained via the Agrobacterium-mediated transformation contained 1 to 2 copies and that, via the particle bombardment, the transgenic plants contained multiple copies (more than 2) of the apu gene in the genomes.
The transformed rice calli were cultured in liquid MS medium to generate suspension cell culture. Because APU was expressed with signal peptide or propeptide sequence in most of the transgenic lines, the culture media were collected for analysis of APU accumulation. The amount of APU in the media of transformed rice suspension cell cultures was determined using ELISA and the purified E.
coli-expressed APU as a standard. As shown in Fig. 3, the amount of APU in media of _ transformed suspension cells was significantly higher than that in media of non-transformed cells. In media of cells carrying aAmy3 or aAmy8 promoters, the amount of APU was higher in the absence of sucrose than in the presence of sucrose.
Surprisingly, although the GIuB-I promoter had been shown to confer endosperm-specific expression in developing rice seeds, it was found that APU
was also expressed in cultured rice suspension cells. In media of cells carrying the GIuB-1 promoter, the amount of APU was higher in the presence of sucrose than in the absence of sucrose. Additionally, APU expressed without a signal peptide sequence was also present in the culture media. Computer analysis indicated that the N-terminal of APU had amino acid sequence features resembling a signal peptide sequence, which might explain the secretion of APU into the culture medium without a leader peptide added. Thus, it was discovered that APU without a signal peptide sequence could be secreted into the culture medium.
Transgenic germinated rice seedlseedling contains high level ofAPU.
Transgenic calli carrying apu under the control of an a-amylase or glutelin gene promoter and with or without signal peptide sequence were regenerated. These transgenic plants were self fertilized for two generations, and the T2 homozygous seeds were obtained.
15 Homozygosity of transgenic seeds was determined by germination of 25 transgenic seeds in water containing 50 pg/ml hygromycin for 7 days, and then calculating the ratio between numbers of growing and non-growing seeds.
Homozygous seeds was expected to germinate and grow under hygromycin treatment. Five T2 homozygous seeds from each transgenic rice line carrying 20 various constructs were germinated and grown for S days. The entire germinated seeds/seedlings were collected, and the APU levels in cell extracts were determined using ELISA and purified E. coli-expressed APU as a standard. The average APU
level expressed under the control of either an a-amylase or glutelin gene promoter was higher than that of the non-transformants (Fig. 4). The expression of APU
in 25 germinated rice seed/seedling was unexpected, because it was known that the GIuB-I promoter was expressed specifically in endosperm during the development of the seed.
Transgenic matLrre rice seeds contain high levels ofAPU. Five T2 homozygous seeds of each transgenic rice line carrying a transgene were selected for 30 APU analysis. The embryo and endosperm of mature seeds were separately collected and homogenized in buffer to form an extract. APU levels in cell extracts were determined using ELISA. The average APU level expressed under the control of either an a,-amylase or glutelin gene promoter in transgenic seeds was higher than that in the non-transformed seed (Fig. 5). Unexpectedly, the GIuB-1 promoter 5 conferred APU expression in embryo. Additionally, the fact that crAmy3 and crAnry8 promoters conferred APU expression in embryo and endosperm of mature seed was also unexpected because it was known that a-amylase genes were expressed specifically in endosperm or transiently in embryo of germinating seed and not in the mature seed.
10 Trarasgenic germinated rice seedlseedling contains APU with high specific activity. The data in Fig. 4 indicated that the APU level was significantly higher in transgenic germinated seed/seedling than in the non-transformed control. To compare the specific activity of recombinant APU expressed in transgenic germinated seed/seedling, five T2 homozygous seeds of each transgenic rice lines 15 carrying various constructs were germinated and grown for 5 days. Cell extracts of the entire germinated seed/seedlings were prepared, and the APU level in the cell extract was determined using ELISA. APU activity per amount of APU in the cell extracts was determined after incubation of the cell extract at 90°C
for 30 minutes.
As shown in Fig. 6, the specific activity of APU present in transgenic germinated 20 seed/seedling varied from line to line regardless of the construct used.
Interestingly, the specific activity of APU expressed in transgenic germinated seed/seedling was two to seven fold higher than that of the E. coli-expressed APU. The reason for this surprising result could be that there are many endogenous hydrolytic enzymes present in the rice endosperm. These hydrolytic enzymes may have a synergistic 25 effect on the APU activity present in germinated seeds. Alternatively, or in conjunction, the post-translationally modified APU in the germinated seeds may have increased the enzyme's specific activity, which resulted in the observed increase in APU activity. Note that there are three potential glycosylation sites in the APU polypeptide, which may be differentially glycosylated depending on the 30 production method used. Thus, besides the above-mentioned advantages of expressing APU in transgenic germinated seeds, the specific activity of the recombinant enzyme was also increased.
Transgenic rice seed and germinated seedlseedling produce high level of sugars. The results summarized in Figs. 4 and 5 revealed that APU level is 5 significantly higher in transgenic mature seed and germinated seed/seedling, than in the non-transformed control. To determine whether transgenic seeds produce higher levels of soluble sugars than the non-transformants, five T2 homozygous seeds of each transgenic rice line carrying apu under the control of the GIuB-1 promoter were homogenized in water and incubated at 85°C for 2 hours. As shown in Fig. 7, the 10 concentration of soluble sugar in transgenic seed was higher than that in the non-transformed seed. Five T2 homozygous seeds of each transgenic rice line carrying apu under the control of crAmy3 and cz.Anry8 promoter were also homogenized in water and incubated at 90°C for 30 minutes. As shown in Fig. 8, the concentration of sugar in germinated seed/seedling was higher than that in the non-transformed 15 control. These results demonstrated that the increased level of APU in transgenic seed or germinated seed/seedling facilitated production of sugars from seed starch without addition of exogenous APU.
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT: ACADMIA SINICA
(ii) TITLE OF INVENTION: PROTEIN PRODUCTION IN TRANSGENIC PLANT
SEEDS
(iii) NUMBER OF SEQUENCES: 28 (iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: Swabey Ogilvy Renault (B) STREET: 1981 McGill College - Suite 1600 (C) CITY: Montreal (D) STATE: Quebec (E) COUNTRY: Canada (F) ZIP: H3A 2Y3 (v) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: PatentIn Release #1.0, Version #1.25 (vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER: CA 2,309,342 (B) FILING DATE: 2000-06-14 (C) CLASSIFICATION: AO1H-5/00 (vii) PRIOR APPLICATION DATA:
(A) APPLICATION NUMBER:
(B) FILING DATE:
(C) CLASSIFICATION:
(viii) ATTORNEY/AGENT INFORMATION:
(A) NAME: CAWTHORN, Christian (B) REGISTRATION NUMBER: 11005 (C) REFERENCE/DOCKET NUMBER: 6070-222 CC
(ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: (514) 847-4256 (B) TELEFAX: (514) 288-8389 (C) TELEX:
(2) INFORMATION FOR SEQ ID N0: 1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:
26a ttaagcgata tcgccaaggc cccggaacag a 31 (2) INFORMATION FOR SEQ ID NO: 2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 24 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:
acgcaggatc cacctcataa aacc 24 (2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:
acggcggata tccagagtga gccggagctg a 31 (2) INFORMATION FOR SEQ ID NO: 4:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 4:
aggttggatc cttacaaact gcacgaaggg t 31 (2) INFORMATION FOR SEQ ID NO: 5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 26b (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:
cgggatccta gctttagcta tagcgat 27 (2) INFORMATION FOR SEQ ID N0: 6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:
tccccgcggg tcctctaagt gaaccgt 27 (2) INFORMATION FOR SEQ ID N0: 7:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 7:
tccggatccc agatcgttca aacattt 27 (2) INFORMATION FOR SEQ ID NO: 8:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 26 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence 26c (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8:
agcccgcggg atcgatctag taacat 26 (2) INFORMATION FOR SEQ ID N0: 9:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:
accgggtcga cgtatacatg tcacctaca 29 (2) INFORMATION FOR SEQ ID N0: 10:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STR.ANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10:
ggtgatatcc aggacttgcc cggctgt 27 (2) INFORMATION FOR SEQ ID NO: 11:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 25 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11:
gctctagaaa tctgagcgca cgatg 25 26d (2) INFORMATION FOR SEQ ID N0: 12:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 12:
tccccgcggt aagcattaag cagtgca 27 (2) INFORMATION FOR SEQ ID NO: 13:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 13:
ggggaattcg atctcgattt ttgaggaat 29 (2) INFORMATION FOR SEQ ID N0: 14:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14:
gggggatccc atagctattt gtacttgct 29 (2) INFORMATION FOR SEQ ID NO: 15:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear 26e (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotidefor PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID
NO: 15:
gggggatccgggattaaata gctgggcca 29 (2) INFORMATION
FOR SEQ
ID N0:
16:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotidefor PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID
NO: 16:
gggggatcccctcactttcc gaagtggtt 29 (2) INFORMATION
FOR SEQ
ID N0:
17:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 25 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotidefor PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID
N0: 17:
cgggatccttaagcttgcat cttga 25 (2) INFORMATION
FOR SEQ
ID N0:
18:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 33 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotidefor PCR
26f (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18:
ccggcggccg cctacatatt ttccccttgg cca 33 (2) INFORMATION FOR SEQ ID NO: 19:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 19:
tccgagctcc agatcgttca aacattt 27 (2) INFORMATION FOR SEQ ID N0: 20:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 26 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20:
agcgagctcg atcgatctag taacat 26 (2) INFORMATION FOR SEQ ID N0: 21:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21:
cgccgcggta gctttagcta tagcgat 27 (2) INFORMATION FOR SEQ ID NO: 22:
(i) SEQUENCE CHARACTERISTICS:
26g (A) LENGTH: 27 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22:
tccccgcggg tcctctaagt gaaccgt 27 (2) INFORMATION FOR SEQ ID NO: 23:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23:
cgcatatgtt aagcttgcat cttgattc 28 (2) INFORMATION FOR SEQ ID NO: 24:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 24:
ccgctcgagc tacatatttt ccccttggcc a 31 (2) INFORMATION FOR SEQ ID N0: 25:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence 26h a (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25:
cggaattcgc caaggcgccg gagcagac 28 (2) INFORMATION FOR SEQ ID N0: 26:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 26:
gctctagata cgccttcgcc ggatggct 28 (2) INFORMATION FOR SEQ ID NO: 27:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 24 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 27:
cccgaattca tgaaatactg gcag 24 (2) INFORMATION FOR SEQ ID NO: 28:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 24 (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (vi) ORIGINAL SOURCE:
(A) ORGANISM: Artificial Sequence (ix) FEATURE:
(D) OTHER INFORMATION: oligonucleotide for PCR
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 28:
cccgagctct tacgccttcg ccgg 24 26i
Claims (29)
1. A transgenic plant whose genomic DNA comprises a gene comprising a promoter and a nucleotide sequence encoding a hydrolytic enzyme and operably linked to the promoter, wherein the promoter drives expression of the hydrolytic enzyme in a plant seed tissue of a developing seed, germinating seed, germinated seed, or seedling of the transgenic plant.
2. The transgenic plant of claim 1, wherein the hydrolytic enzyme hydrolyzes a substrate naturally occurring in the plant seed tissue of the transgenic plant.
3. The transgenic plant of claim 1, wherein the plant is a rice, barley, rye, oat, or canola plant.
4. The transgenic plant of claim 1, wherein the promoter is an .alpha.-amylase gene promoter.
5. The transgenic plant of claim 4, wherein the promoter is an .alpha.Amy8 promoter.
6. The transgenic plant of claim 1, wherein the promoter is a glutelin gene promoter.
7. The transgenic plant of claim l, wherein the enzyme is a phytase.
8. The transgenic plant of claim 1, wherein the enzyme is an amylopullulanase or .alpha.-amylase.
9. A transgenic seed produced from the transgenic plant of claim 1.
10. The transgenic seed of claim 9, wherein the seed has been germinated.
11. A transgenic seed produced from the transgenic plant of claim 2.
12. The transgenic seed of claim 11, wherein the seed has been germinated.
13. A transgenic seed produced from the transgenic plant of claim 3.
14. The transgenic seed of claim 13, wherein the seed has been germinated.
15. A transgenic seed produced from the transgenic plant of claim 4
16. The transgenic seed of claim 15, wherein the seed has been germinated.
17. A transgenic seed produced from the transgenic plant of claim 5.
18. The transgenic seed of claim 17, wherein the seed has been germinated.
19. A transgenic seed produced from the transgenic plant of claim 6.
20. The transgenic seed of claim 19, wherein the seed has been germinated.
21. A transgenic seed produced from the transgenic plant of claim 7.
22. The transgenic seed of claim 21, wherein the seed has been germinated.
23. A transgenic seed produced from the transgenic plant of claim 8.
24. The transgenic seed of claim 23, wherein the seed has been germinated.
25. A method of producing a hydrolytic enzyme, the method comprising providing the transgenic plant of claim l, harvesting a transgenic seed from the transgenic plant, and germinating the transgenic seed to produce the hydrolytic enzyme.
26. The method of claim 25, further comprising isolating the hydrolytic enzyme from the transgenic seed.
27. A method of producing a polypeptide, the method comprising providing a transgenic plant whose genomic DNA comprises a gene comprising an .alpha.-amylase promoter and a nucleotide sequence encoding a polypeptide and operably linked to the promoter;
harvesting a transgenic seed from the transgenic plant;
germinating the transgenic seed to produce a mature seed; and isolating the polypeptide from the mature seed.
harvesting a transgenic seed from the transgenic plant;
germinating the transgenic seed to produce a mature seed; and isolating the polypeptide from the mature seed.
28. The method of claim 27, wherein, in the isolating step, the polypeptide is isolated from an embryo or endosperm of the mature seed.
29. A method of producing a polypeptide, the method comprising providing a transgenic plant whose genomic DNA comprises a gene comprising a glutelin gene promoter and a nucleotide sequence encoding a polypeptide and operably linked to the promoter;
harvesting a transgenic seed from the transgenic plant;
germinating the transgenic seed; and isolating the polypeptide from an embryo_or endosperm tissue of the seed.
harvesting a transgenic seed from the transgenic plant;
germinating the transgenic seed; and isolating the polypeptide from an embryo_or endosperm tissue of the seed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2309342 CA2309342A1 (en) | 2000-06-14 | 2000-06-14 | Protein production in transgenic plant seeds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2309342 CA2309342A1 (en) | 2000-06-14 | 2000-06-14 | Protein production in transgenic plant seeds |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2309342A1 true CA2309342A1 (en) | 2001-12-14 |
Family
ID=4166233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2309342 Abandoned CA2309342A1 (en) | 2000-06-14 | 2000-06-14 | Protein production in transgenic plant seeds |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2309342A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112552371A (en) * | 2020-12-24 | 2021-03-26 | 常州市芙丽佳生物科技有限公司 | Method for preparing olive kernel extract based on extraction and purification technology |
-
2000
- 2000-06-14 CA CA 2309342 patent/CA2309342A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112552371A (en) * | 2020-12-24 | 2021-03-26 | 常州市芙丽佳生物科技有限公司 | Method for preparing olive kernel extract based on extraction and purification technology |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3938401B2 (en) | Production of enzymes in seeds and their use | |
JP3471795B2 (en) | Phytase expression in plants | |
US5593963A (en) | Expression of phytase in plants | |
US5714474A (en) | Production of enzymes in seeds and their use | |
US5994628A (en) | Process for protein production in plants | |
Ponstein et al. | Stable expression of phytase (phyA) in canola (Brassica napus) seeds: towards a commercial product | |
EP2862930B1 (en) | Lowering saturated fatty acid content of plant seeds | |
JP3400050B2 (en) | Gene expression system comprising promoter region of alpha-amylase gene | |
ZA200103557B (en) | Novel expression cassette for expressing genes in plant seed. | |
WO1998005785A1 (en) | Plant phytases and biotechnological applications | |
US6022846A (en) | Expression of phytase in plants | |
US20030135884A1 (en) | Transgenic seeds expressing amylopullulanase and uses therefor | |
CN101153285A (en) | A kind of preparation method of transgenic plant expressing phytase | |
JP2002209462A (en) | Protein production in transgenic plant seeds | |
EP1164194A2 (en) | Protein production in transgenic plant seeds | |
AU782957B2 (en) | Plant seed endosperm-specific promoter | |
CN114457181A (en) | Methods of identifying corn event 4588.259 in a sample and methods of using the same | |
CA2309342A1 (en) | Protein production in transgenic plant seeds | |
Sapara et al. | Expression of B. subtilis Phytase gene driven by fruit specific E8 promoter for enhanced minerals, metabolites and phytonutrient in cucumber fruit | |
US20040088750A1 (en) | Production of enzymes in seeds and their use | |
Qiao-quan et al. | Transgenic expression of the recombinant phytase in rice (Oryza sativa) | |
JP3600614B2 (en) | Phytase expression in plants | |
JP3600614B6 (en) | Expression of phytase in plants | |
US7045681B2 (en) | DNA sequences capable of expressing foreign proteins and metabolites in dicotyledonous plants and cell culture | |
JP2005137293A (en) | Method for producing extraneous phytase in plant through combination of codon modification with extracellular secretion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |